The Free Online 2015 HCPCS Code Lookup Website
HCPCS G Codes (938 active, 274 terminated) >
  • 2015 HCPCS G0008 Administration of influenza virus vaccine
  • 2015 HCPCS G0009 Administration of pneumococcal vaccine
  • 2015 HCPCS G0010 Administration of hepatitis b vaccine
  • 2015 HCPCS G0027 Semen analysis; presence and/or motility of sperm excluding huhner
  • 2015 HCPCS G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination
  • 2015 HCPCS G0102 Prostate cancer screening; digital rectal examination
  • 2015 HCPCS G0103 Prostate cancer screening; prostate specific antigen test (psa)
  • 2015 HCPCS G0104 Colorectal cancer screening; flexible sigmoidoscopy
  • 2015 HCPCS G0105 Colorectal cancer screening; colonoscopy on individual at high risk
  • 2015 HCPCS G0106 Colorectal cancer screening; alternative to g0104, screening sigmoidoscopy, barium enema
  • 2015 HCPCS G0108 Diabetes outpatient self-management training services, individual, per 30 minutes
  • 2015 HCPCS G0109 Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes
  • 2015 HCPCS G0117 Glaucoma screening for high risk patients furnished by an optometrist or ophthalmologist
  • 2015 HCPCS G0118 Glaucoma screening for high risk patient furnished under the direct supervision of an optometrist or ophthalomologist
  • 2015 HCPCS G0120 Colorectal cancer screening; alternative to g0105, screening colonoscopy, barium enema.
  • 2015 HCPCS G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk
  • 2015 HCPCS G0122 Colorectal cancer screening; barium enema
  • 2015 HCPCS G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision
  • 2015 HCPCS G0124 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician
  • 2015 HCPCS G0127 Trimming of dystrophic nails, any number
  • 2015 HCPCS G0128 Direct (face-to-face with patient) skilled nursing services of a registered nurse provided in a comprehensive outpatient rehabilitation facility, each 10 minutes beyond the first 5 minutes
  • 2015 HCPCS G0129 Occupational therapy services requiring the skills of a qualified occupational therapist, furnished as a component of a partial hospitalization treatment program, per session (45 minutes or more)
  • 2015 HCPCS G0130 Single energy x-ray absorptiometry (sexa) bone density study, one or more sites; appendicular skeleton (peripheral) (eg, radius, wrist, heel)
  • 2015 HCPCS G0141 Screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician
  • 2015 HCPCS G0143 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with manual screening and rescreening by cytotechnologist under physician supervision
  • 2015 HCPCS G0144 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system, under physician supervision
  • 2015 HCPCS G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision
  • 2015 HCPCS G0147 Screening cytopathology smears, cervical or vaginal, performed by automated system under physician supervision
  • 2015 HCPCS G0148 Screening cytopathology smears, cervical or vaginal, performed by automated system with manual rescreening
  • 2015 HCPCS G0151 Services performed by a qualified physical therapist in the home health or hospice setting, each 15 minutes
  • 2015 HCPCS G0152 Services performed by a qualified occupational therapist in the home health or hospice setting, each 15 minutes
  • 2015 HCPCS G0153 Services performed by a qualified speech-language pathologist in the home health or hospice setting, each 15 minutes
  • 2015 HCPCS G0154 Direct skilled nursing services of a licensed nurse (lpn or rn) in the home health or hospice setting, each 15 minutes
  • 2015 HCPCS G0155 Services of clinical social worker in home health or hospice settings, each 15 minutes
  • 2015 HCPCS G0156 Services of home health/hospice aide in home health or hospice settings, each 15 minutes
  • 2015 HCPCS G0157 Services performed by a qualified physical therapist assistant in the home health or hospice setting, each 15 minutes
  • 2015 HCPCS G0158 Services performed by a qualified occupational therapist assistant in the home health or hospice setting, each 15 minutes
  • 2015 HCPCS G0159 Services performed by a qualified physical therapist, in the home health setting, in the establishment or delivery of a safe and effective physical therapy maintenance program, each 15 minutes
  • 2015 HCPCS G0160 Services performed by a qualified occupational therapist, in the home health setting, in the establishment or delivery of a safe and effective occupational therapy maintenance program, each 15 minutes
  • 2015 HCPCS G0161 Services performed by a qualified speech-language pathologist, in the home health setting, in the establishment or delivery of a safe and effective speech-language pathology maintenance program, each 15 minutes
  • 2015 HCPCS G0162 Skilled services by a registered nurse (rn) for management and evaluation of the plan of care; each 15 minutes (the patient's underlying condition or complication requires an rn to ensure that essential non-skilled care achieves its purpose in the home he
  • 2015 HCPCS G0163 Skilled services of a licensed nurse (lpn or rn) for the observation and assessment of the patient's condition, each 15 minutes (the change in the patient's condition requires skilled nursing personnel to identify and evaluate the patient's need for possi
  • 2015 HCPCS G0164 Skilled services of a licensed nurse (lpn or rn), in the training and/or education of a patient or family member, in the home health or hospice setting, each 15 minutes
  • 2015 HCPCS G0166 External counterpulsation, per treatment session
  • 2015 HCPCS G0168 Wound closure utilizing tissue adhesive(s) only
  • 2015 HCPCS G0173 TERMINATED 12/31/2014 : Linear accelerator based stereotactic radiosurgery, complete course of therapy in one session
  • 2015 HCPCS G0175 Scheduled interdisciplinary team conference (minimum of three exclusive of patient care nursing staff) with patient present
  • 2015 HCPCS G0176 Activity therapy, such as music, dance, art or play therapies not for recreation, related to the care and treatment of patient's disabling mental health problems, per session (45 minutes or more)
  • 2015 HCPCS G0177 Training and educational services related to the care and treatment of patient's disabling mental health problems per session (45 minutes or more)
  • 2015 HCPCS G0179 Physician re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial i
  • 2015 HCPCS G0180 Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial impl
  • 2015 HCPCS G0181 Physician supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of
  • 2015 HCPCS G0182 Physician supervision of a patient under a medicare-approved hospice (patient not present) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of care plans, review of subsequent reports of patie
  • 2015 HCPCS G0186 Destruction of localized lesion of choroid (for example, choroidal neovascularization); photocoagulation, feeder vessel technique (one or more sessions)
  • 2015 HCPCS G0202 Screening mammography, producing direct digital image, bilateral, all views
  • 2015 HCPCS G0204 Diagnostic mammography, producing direct 2-d digital image, bilateral, all views
  • 2015 HCPCS G0206 Diagnostic mammography, producing direct 2-d digital image, unilateral, all views
  • 2015 HCPCS G0219 Pet imaging whole body; melanoma for non-covered indications
  • 2015 HCPCS G0235 Pet imaging, any site, not otherwise specified
  • 2015 HCPCS G0237 Therapeutic procedures to increase strength or endurance of respiratory muscles, face to face, one on one, each 15 minutes (includes monitoring)
  • 2015 HCPCS G0238 Therapeutic procedures to improve respiratory function, other than described by g0237, one on one, face to face, per 15 minutes (includes monitoring)
  • 2015 HCPCS G0239 Therapeutic procedures to improve respiratory function or increase strength or endurance of respiratory muscles, two or more individuals (includes monitoring)
  • 2015 HCPCS G0245 Initial physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) which must include: (1) the diagnosis of lops, (2) a patient history, (3) a physical examination that con
  • 2015 HCPCS G0246 Follow-up physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include at least the following: (1) a patient history, (2) a physical examination that includes: (a)
  • 2015 HCPCS G0247 Routine foot care by a physician of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include, the local care of superficial wounds (i.e. superficial to muscle and fascia) and at least the following
  • 2015 HCPCS G0248 Demonstration, prior to initiation of home inr monitoring, for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria, under the direction of a physician; includes: face-t
  • 2015 HCPCS G0249 Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in th
  • 2015 HCPCS G0250 Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequen
  • 2015 HCPCS G0251 TERMINATED 12/31/2014 : Linear accelerator based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, maximum five sessions per course of treatment
  • 2015 HCPCS G0252 Pet imaging, full and partial-ring pet scanners only, for initial diagnosis of breast cancer and/or surgical planning for breast cancer (e.g. initial staging of axillary lymph nodes)
  • 2015 HCPCS G0255 Current perception threshold/sensory nerve conduction test, (snct) per limb, any nerve
  • 2015 HCPCS G0257 Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility
  • 2015 HCPCS G0259 Injection procedure for sacroiliac joint; arthrograpy
  • 2015 HCPCS G0260 Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography
  • 2015 HCPCS G0268 Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing
  • 2015 HCPCS G0269 Placement of occlusive device into either a venous or arterial access site, post surgical or interventional procedure (e.g. angioseal plug, vascular plug)
  • 2015 HCPCS G0270 Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face w
  • 2015 HCPCS G0271 Medical nutrition therapy, reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition, or treatment regimen (including additional hours needed for renal disease), group (2 or more individu
  • 2015 HCPCS G0275 TERMINATED 12/31/2013 : Renal angiography, non-selective, one or both kidneys, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of any catheter in the abdominal aorta at or near the origins (ostia) of the renal
  • 2015 HCPCS G0276 Blinded procedure for lumbar stenosis, percutaneous image-guided lumbar decompression (pild) or placebo-control, performed in an approved coverage with evidence development (ced) clinical trial
  • 2015 HCPCS G0277 Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval
  • 2015 HCPCS G0278 Iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aort
  • 2015 HCPCS G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to g0204 or g0206)
  • 2015 HCPCS G0281 Electrical stimulation, (unattended), to one or more areas, for chronic stage iii and stage iv pressure ulcers, arterial ulcers, diabetic ulcers, and venous statsis ulcers not demonstrating measurable signs of healing after 30 days of conventional care, a
  • 2015 HCPCS G0282 Electrical stimulation, (unattended), to one or more areas, for wound care other than described in g0281
  • 2015 HCPCS G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care
  • 2015 HCPCS G0288 Reconstruction, computed tomographic angiography of aorta for surgical planning for vascular surgery
  • 2015 HCPCS G0289 Arthroscopy, knee, surgical, for removal of loose body, foreign body, debridement/shaving of articular cartilage (chrondroplasty) at the time of other surgical knee arthroscopy in a different compartment of the same knee
  • 2015 HCPCS G0290 TERMINATED 12/31/2012 : Transcatheter placement of a drug eluting intracoronary stent(s), percutaneous, with or without other therapeutic intervention, any method; single vessel
  • 2015 HCPCS G0291 TERMINATED 12/31/2012 : Transcatheter placement of a drug eluting intracoronary stent(s), percutaneous, with or without other therapeutic intervention, any method; each additional vessel
  • 2015 HCPCS G0293 Noncovered surgical procedure(s) using conscious sedation, regional, general or spinal anesthesia in a medicare qualifying clinical trial, per day
  • 2015 HCPCS G0294 Noncovered procedure(s) using either no anesthesia or local anesthesia only, in a medicare qualifying clinical trial, per day
  • 2015 HCPCS G0295 Electromagnetic therapy, to one or more areas, for wound care other than described in g0329 or for other uses
  • 2015 HCPCS G0302 Pre-operative pulmonary surgery services for preparation for lvrs, complete course of services, to include a minimum of 16 days of services
  • 2015 HCPCS G0303 Pre-operative pulmonary surgery services for preparation for lvrs, 10 to 15 days of services
  • 2015 HCPCS G0304 Pre-operative pulmonary surgery services for preparation for lvrs, 1 to 9 days of services
  • 2015 HCPCS G0305 Post-discharge pulmonary surgery services after lvrs, minimum of 6 days of services
  • 2015 HCPCS G0306 Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count
  • 2015 HCPCS G0307 Complete (cbc), automated (hgb, hct, rbc, wbc; without platelet count)
  • 2015 HCPCS G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous
  • 2015 HCPCS G0329 Electromagnetic therapy, to one or more areas for chronic stage iii and stage iv pressure ulcers, arterial ulcers, diabetic ulcers and venous stasis ulcers not demonstrating measurable signs of healing after 30 days of conventional care as part of a thera
  • 2015 HCPCS G0333 Pharmacy dispensing fee for inhalation drug(s); initial 30-day supply as a beneficiary
  • 2015 HCPCS G0337 Hospice evaluation and counseling services, pre-election
  • 2015 HCPCS G0339 Image-guided robotic linear accelerator-based stereotactic radiosurgery, complete course of therapy in one session or first session of fractionated treatment
  • 2015 HCPCS G0340 Image-guided robotic linear accelerator-based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatm
  • 2015 HCPCS G0341 Percutaneous islet cell transplant, includes portal vein catheterization and infusion
  • 2015 HCPCS G0342 Laparoscopy for islet cell transplant, includes portal vein catheterization and infusion
  • 2015 HCPCS G0343 Laparotomy for islet cell transplant, includes portal vein catheterization and infusion
  • 2015 HCPCS G0364 Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service
  • 2015 HCPCS G0365 Vessel mapping of vessels for hemodialysis access (services for preoperative vessel mapping prior to creation of hemodialysis access using an autogenous hemodialysis conduit, including arterial inflow and venous outflow)
  • 2015 HCPCS G0372 Physician service required to establish and document the need for a power mobility device
  • 2015 HCPCS G0378 Hospital observation service, per hour
  • 2015 HCPCS G0379 Direct admission of patient for hospital observation care
  • 2015 HCPCS G0380 Level 1 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or
  • 2015 HCPCS G0381 Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or
  • 2015 HCPCS G0382 Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or
  • 2015 HCPCS G0383 Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or
  • 2015 HCPCS G0384 Level 5 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or
  • 2015 HCPCS G0389 Ultrasound b-scan and/or real time with image documentation; for abdominal aortic aneurysm (aaa) screening
  • 2015 HCPCS G0390 Trauma response team associated with hospital critical care service
  • 2015 HCPCS G0396 Alcohol and/or substance (other than tobacco) abuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes
  • 2015 HCPCS G0397 Alcohol and/or substance (other than tobacco) abuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes
  • 2015 HCPCS G0398 Home sleep study test (hst) with type ii portable monitor, unattended; minimum of 7 channels: eeg, eog, emg, ecg/heart rate, airflow, respiratory effort and oxygen saturation
  • 2015 HCPCS G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation
  • 2015 HCPCS G0400 Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels
  • 2015 HCPCS G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment
  • 2015 HCPCS G0403 Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report
  • 2015 HCPCS G0404 Electrocardiogram, routine ecg with 12 leads; tracing only, without interpretation and report, performed as a screening for the initial preventive physical examination
  • 2015 HCPCS G0405 Electrocardiogram, routine ecg with 12 leads; interpretation and report only, performed as a screening for the initial preventive physical examination
  • 2015 HCPCS G0406 Follow-up inpatient consultation, limited, physicians typically spend 15 minutes communicating with the patient via telehealth
  • 2015 HCPCS G0407 Follow-up inpatient consultation, intermediate, physicians typically spend 25 minutes communicating with the patient via telehealth
  • 2015 HCPCS G0408 Follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth
  • 2015 HCPCS G0409 Social work and psychological services, directly relating to and/or furthering the patient's rehabilitation goals, each 15 minutes, face-to-face; individual (services provided by a corf-qualified social worker or psychologist in a corf)
  • 2015 HCPCS G0410 Group psychotherapy other than of a multiple-family group, in a partial hospitalization setting, approximately 45 to 50 minutes
  • 2015 HCPCS G0411 Interactive group psychotherapy, in a partial hospitalization setting, approximately 45 to 50 minutes
  • 2015 HCPCS G0412 Open treatment of iliac spine(s), tuberosity avulsion, or iliac wing fracture(s), unilateral or bilateral for pelvic bone fracture patterns which do not disrupt the pelvic ring includes internal fixation, when performed
  • 2015 HCPCS G0413 Percutaneous skeletal fixation of posterior pelvic bone fracture and/or dislocation, for fracture patterns which disrupt the pelvic ring, unilateral or bilateral, (includes ilium, sacroiliac joint and/or sacrum)
  • 2015 HCPCS G0414 Open treatment of anterior pelvic bone fracture and/or dislocation for fracture patterns which disrupt the pelvic ring, unilateral or bilateral, includes internal fixation when performed (includes pubic symphysis and/or superior/inferior rami)
  • 2015 HCPCS G0415 Open treatment of posterior pelvic bone fracture and/or dislocation, for fracture patterns which disrupt the pelvic ring, unilateral or bilateral, includes internal fixation, when performed (includes ilium, sacroiliac joint and/or sacrum)
  • 2015 HCPCS G0416 Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method
  • 2015 HCPCS G0417 TERMINATED 12/31/2014 : Surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, 21-40 specimens
  • 2015 HCPCS G0418 TERMINATED 12/31/2014 : Surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, 41-60 specimens
  • 2015 HCPCS G0419 TERMINATED 12/31/2014 : Surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, >60 specimens
  • 2015 HCPCS G0420 Face-to-face educational services related to the care of chronic kidney disease; individual, per session, per one hour
  • 2015 HCPCS G0421 Face-to-face educational services related to the care of chronic kidney disease; group, per session, per one hour
  • 2015 HCPCS G0422 Intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session
  • 2015 HCPCS G0423 Intensive cardiac rehabilitation; with or without continuous ecg monitoring; without exercise, per session
  • 2015 HCPCS G0424 Pulmonary rehabilitation, including exercise (includes monitoring), one hour, per session, up to two sessions per day
  • 2015 HCPCS G0425 Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth
  • 2015 HCPCS G0426 Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth
  • 2015 HCPCS G0427 Telehealth consultation, emergency department or initial inpatient, typically 70 minutes or more communicating with the patient via telehealth
  • 2015 HCPCS G0428 Collagen meniscus implant procedure for filling meniscal defects (e.g., cmi, collagen scaffold, menaflex)
  • 2015 HCPCS G0429 Dermal filler injection(s) for the treatment of facial lipodystrophy syndrome (lds) (e.g., as a result of highly active antiretroviral therapy)
  • 2015 HCPCS G0431 Drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter
  • 2015 HCPCS G0432 Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening
  • 2015 HCPCS G0433 Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening
  • 2015 HCPCS G0434 Drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter
  • 2015 HCPCS G0435 Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening
  • 2015 HCPCS G0436 Smoking and tobacco cessation counseling visit for the asymptomatic patient; intermediate, greater than 3 minutes, up to 10 minutes
  • 2015 HCPCS G0437 Smoking and tobacco cessation counseling visit for the asymptomatic patient; intensive, greater than 10 minutes
  • 2015 HCPCS G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit
  • 2015 HCPCS G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
  • 2015 HCPCS G0440 TERMINATED 12/31/2011 : Application of tissue cultured allogeneic skin substitute or dermal substitute; for use on lower limb, includes the site preparation and debridement if performed; first 25 sq cm or less
  • 2015 HCPCS G0441 TERMINATED 12/31/2011 : Application of tissue cultured allogeneic skin substitute or dermal substitute; for use on lower limb, includes the site preparation and debridement if performed; each additional 25 sq cm
  • 2015 HCPCS G0442 Annual alcohol misuse screening, 15 minutes
  • 2015 HCPCS G0443 Brief face-to-face behavioral counseling for alcohol misuse, 15 minutes
  • 2015 HCPCS G0444 Annual depression screening, 15 minutes
  • 2015 HCPCS G0445 High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, individual, includes: education, skills training and guidance on how to change sexual behavior; performed semi-annually, 30 minutes
  • 2015 HCPCS G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes
  • 2015 HCPCS G0447 Face-to-face behavioral counseling for obesity, 15 minutes
  • 2015 HCPCS G0448 Insertion or replacement of a permanent pacing cardioverter-defibrillator system with transvenous lead(s), single or dual chamber with insertion of pacing electrode, cardiac venous system, for left ventricular pacing
  • 2015 HCPCS G0451 Development testing, with interpretation and report, per standardized instrument form
  • 2015 HCPCS G0452 Molecular pathology procedure; physician interpretation and report
  • 2015 HCPCS G0453 Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure)
  • 2015 HCPCS G0454 Physician documentation of face-to-face visit for durable medical equipment determination performed by nurse practitioner, physician assistant or clinical nurse specialist
  • 2015 HCPCS G0455 Preparation with instillation of fecal microbiota by any method, including assessment of donor specimen
  • 2015 HCPCS G0456 TERMINATED 12/31/2014 : Negative pressure wound therapy, (e.g. vacuum assisted drainage collection) using a mechanically-powered device, not durable medical equipment, including provision of cartridge and dressing(s), topical application(s), wound assessment, and instructions fo
  • 2015 HCPCS G0457 TERMINATED 12/31/2014 : Negative pressure wound therapy, (e.g. vacuum assisted drainage collection) using a mechanically-powered device, not durable medical equipment, including provision of cartridge and dressing(s), topical application(s), wound assessment, and instructions fo
  • 2015 HCPCS G0458 Low dose rate (ldr) prostate brachytherapy services, composite rate
  • 2015 HCPCS G0459 Inpatient telehealth pharmacologic management, including prescription, use, and review of medication with no more than minimal medical psychotherapy
  • 2015 HCPCS G0460 Autologous platelet rich plasma for chronic wounds/ulcers, incuding phlebotomy, centrifugation, and all other preparatory procedures, administration and dressings, per treatment
  • 2015 HCPCS G0461 TERMINATED 12/31/2014 : Immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain
  • 2015 HCPCS G0462 TERMINATED 12/31/2014 : Immunohistochemistry or immunocytochemistry, per specimen; each additional single or multiplex antibody stain (list separately in addition to code for primary procedure)
  • 2015 HCPCS G0463 Hospital outpatient clinic visit for assessment and management of a patient
  • 2015 HCPCS G0464 Colorectal cancer screening; stool-based dna and fecal occult hemoglobin (e.g., kras, ndrg4 and bmp3)
  • 2015 HCPCS G0466 Federally qualified health center (fqhc) visit, new patient; a medically-necessary, face-to-face encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of
  • 2015 HCPCS G0467 Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a
  • 2015 HCPCS G0468 Federally qualified health center (fqhc) visit, ippe or awv; a fqhc visit that includes an initial preventive physical examination (ippe) or annual wellness visit (awv) and includes a typical bundle of medicare-covered services that would be furnished per
  • 2015 HCPCS G0469 Federally qualified health center (fqhc) visit, mental health, new patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and
  • 2015 HCPCS G0470 Federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services
  • 2015 HCPCS G0471 Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha)
  • 2015 HCPCS G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s)
  • 2015 HCPCS G0473 Face-to-face behavioral counseling for obesity, group (2-10), 30 minutes
  • 2015 HCPCS G0908 TERMINATED 12/31/2014 : Most recent hemoglobin (hgb) level > 12.0 g/dl
  • 2015 HCPCS G0909 TERMINATED 12/31/2014 : Hemoglobin level measurement not documented, reason not given
  • 2015 HCPCS G0910 TERMINATED 12/31/2014 : Most recent hemoglobin level <= 12.0 g/dl
  • 2015 HCPCS G0911 TERMINATED 12/31/2012 : Assessed level of activity and symptoms
  • 2015 HCPCS G0912 TERMINATED 12/31/2012 : Level of activity and symptoms not assessed
  • 2015 HCPCS G0913 Improvement in visual function achieved within 90 days following cataract surgery
  • 2015 HCPCS G0914 Patient care survey was not completed by patient
  • 2015 HCPCS G0915 Improvement in visual function not achieved within 90 days following cataract surgery
  • 2015 HCPCS G0916 Satisfaction with care achieved within 90 days following cataract surgery
  • 2015 HCPCS G0917 Patient satisfaction survey was not completed by patient
  • 2015 HCPCS G0918 Satisfaction with care not achieved within 90 days following cataract surgery
  • 2015 HCPCS G0919 TERMINATED 12/31/2014 : Influenza immunization ordered or recommended (to be given at alternate location or alternate provider); vaccine not available at time of visit
  • 2015 HCPCS G0920 TERMINATED 12/31/2014 : Type, anatomic location, and activity all documented
  • 2015 HCPCS G0921 TERMINATED 12/31/2014 : Documentation of patient reason(s) for not being able to assess (e.g., patient refuses endoscopic and/or radiologic assessment)
  • 2015 HCPCS G0922 TERMINATED 12/31/2014 : No documentation of disease type, anatomic location, and activity, reason not given
  • 2015 HCPCS G3001 Administration and supply of tositumomab, 450 mg
  • 2015 HCPCS G6001 Ultrasonic guidance for placement of radiation therapy fields
  • 2015 HCPCS G6002 Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy
  • 2015 HCPCS G6003 Radiation treatment delivery, single treatment area,single port or parallel opposed ports, simple blocks or no blocks: up to 5mev
  • 2015 HCPCS G6004 Radiation treatment delivery, single treatment area,single port or parallel opposed ports, simple blocks or no blocks: 6-10mev
  • 2015 HCPCS G6005 Radiation treatment delivery, single treatment area,single port or parallel opposed ports, simple blocks or no blocks: 11-19mev
  • 2015 HCPCS G6006 Radiation treatment delivery, single treatment area,single port or parallel opposed ports, simple blocks or no blocks: 20mev or greater
  • 2015 HCPCS G6007 Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: up to 5mev
  • 2015 HCPCS G6008 Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 6-10mev
  • 2015 HCPCS G6009 Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 11-19mev
  • 2015 HCPCS G6010 Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 20 mev or greater
  • 2015 HCPCS G6011 Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; up to 5mev
  • 2015 HCPCS G6012 Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10mev
  • 2015 HCPCS G6013 Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19mev
  • 2015 HCPCS G6014 Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 20mev or greater
  • 2015 HCPCS G6015 Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session
  • 2015 HCPCS G6016 Compensator-based beam modulation treatment delivery of inverse planned treatment using 3 or more high resolution (milled or cast) compensator, convergent beam modulated fields, per treatment session
  • 2015 HCPCS G6017 Intra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (eg,3d positional tracking, gating, 3d surface tracking), each fraction of treatment
  • 2015 HCPCS G6018 Ileoscopy,through stoma; with transendoscopic stent placement (includes predilation)
  • 2015 HCPCS G6019 Colonoscopy through stoma; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique
  • 2015 HCPCS G6020 Colonoscopy through stoma; with transendoscopic stent placement (includes predilation)
  • 2015 HCPCS G6021 Unlisted procedure, intestine
  • 2015 HCPCS G6022 Sigmoidoscopy, flexible; with ablation of tumor(s), polyp(s), or other lesions(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique
  • 2015 HCPCS G6023 Sigmoidoscopy, flexible; with transendoscopic stent placement (includes predilation)
  • 2015 HCPCS G6024 Colonoscopy, flexible; proximal to splenic flexure; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare tehnique
  • 2015 HCPCS G6025 Colonoscopy, flexible, proximal to splenic flexure; with transendoscopic stent placement (includes predilation)
  • 2015 HCPCS G6027 Anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); diagnostic, including collection of specimen(s) by brushing or washing when performed
  • 2015 HCPCS G6028 Anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); with biopsy(ies)
  • 2015 HCPCS G6030 Amitriptyline
  • 2015 HCPCS G6031 Benzodiazepines
  • 2015 HCPCS G6032 Desipramine
  • 2015 HCPCS G6034 Doxepin
  • 2015 HCPCS G6035 Gold
  • 2015 HCPCS G6036 Assay of imipramine
  • 2015 HCPCS G6037 Nortriptyline
  • 2015 HCPCS G6038 Salicylate
  • 2015 HCPCS G6039 Acetaminophen
  • 2015 HCPCS G6040 Alcohol (ethanol); any specimen except breath
  • 2015 HCPCS G6041 Alkaloids, urine, quantitative
  • 2015 HCPCS G6042 Amphetamine or methamphetamine
  • 2015 HCPCS G6043 Barbiturates, not elsewhere specified
  • 2015 HCPCS G6044 Cocaine or metabolite
  • 2015 HCPCS G6045 Dihydrocodeinone
  • 2015 HCPCS G6046 Dihydromorphinone
  • 2015 HCPCS G6047 Dihydrotestosterone
  • 2015 HCPCS G6048 Dimethadione
  • 2015 HCPCS G6049 Epiandrosterone
  • 2015 HCPCS G6050 Ethchlorvynol
  • 2015 HCPCS G6051 Flurazepam
  • 2015 HCPCS G6052 Meprobamate
  • 2015 HCPCS G6053 Methadone
  • 2015 HCPCS G6054 Methsuximide
  • 2015 HCPCS G6055 Nicotine
  • 2015 HCPCS G6056 Opiate(s), drug and metabolites, each procedure
  • 2015 HCPCS G6057 Phenothiazine
  • 2015 HCPCS G6058 Drug confirmation, each procedure
  • 2015 HCPCS G8126 TERMINATED 12/31/2014 : Patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
  • 2015 HCPCS G8127 TERMINATED 12/31/2014 : Patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
  • 2015 HCPCS G8128 TERMINATED 12/31/2014 : Clinician documented that patient was not an eligible candidate for antidepressant medication during the entire 12 week acute treatment phase measure
  • 2015 HCPCS G8395 Left ventricular ejection fraction (lvef) >= 40% or documentation as normal or mildly depressed left ventricular systolic function
  • 2015 HCPCS G8396 Left ventricular ejection fraction (lvef) not performed or documented
  • 2015 HCPCS G8397 Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy
  • 2015 HCPCS G8398 Dilated macular or fundus exam not performed
  • 2015 HCPCS G8399 Patient with central dual-energy x-ray absorptiometry (dxa) results documented or ordered or pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribed)
  • 2015 HCPCS G8400 Patient with central dual-energy x-ray absorptiometry (dxa) results not documented or not ordered or pharmacologic therapy (other than minerals/vitamins) for osteoporosis not prescribed, reason not given
  • 2015 HCPCS G8401 Clinician documented that patient was not an eligible candidate for screening or therapy for osteoporosis for women measure
  • 2015 HCPCS G8404 Lower extremity neurological exam performed and documented
  • 2015 HCPCS G8405 Lower extremity neurological exam not performed
  • 2015 HCPCS G8406 TERMINATED 12/31/2014 : Clinician documented that patient was not an eligible candidate for lower extremity neurological exam measure
  • 2015 HCPCS G8410 Footwear evaluation performed and documented
  • 2015 HCPCS G8415 Footwear evaluation was not performed
  • 2015 HCPCS G8416 Clinician documented that patient was not an eligible candidate for footwear evaluation measure
  • 2015 HCPCS G8417 Bmi is documented above normal parameters and a follow-up plan is documented
  • 2015 HCPCS G8418 Bmi is documented below normal parameters and a follow-up plan is documented
  • 2015 HCPCS G8419 Bmi documented outside normal parameters, no follow-up plan documented, no reason given
  • 2015 HCPCS G8420 Bmi is documented within normal parameters and no follow-up plan is required
  • 2015 HCPCS G8421 Bmi not documented and no reason is given
  • 2015 HCPCS G8422 Bmi not documented, documentation the patient is not eligible for bmi calculation
  • 2015 HCPCS G8427 Eligible professional attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications
  • 2015 HCPCS G8428 Current list of medications not documented as obtained, updated, or reviewed by the eligible professional, reason not given
  • 2015 HCPCS G8430 Eligible professional attests to documenting in the medical record the patient is not eligible for a current list of medications being obtained, updated, or reviewed by the eligible professional
  • 2015 HCPCS G8431 Screening for clinical depression is documented as being positive and a follow-up plan is documented
  • 2015 HCPCS G8432 Clinical depression screening not documented, reason not given
  • 2015 HCPCS G8433 Screening for clinical depression not documented, documentation stating the patient is not eligible
  • 2015 HCPCS G8440 TERMINATED 12/31/2011 : Documentation of pain assessment (including location, intensity and description) prior to initiation of therapy or documentation of the absence of pain as a result of assessment through discussion with the patient including the use of a standardized tool
  • 2015 HCPCS G8441 TERMINATED 12/31/2011 : No documentation of pain assessment (including location, intensity and description) prior to initiation of therapy
  • 2015 HCPCS G8442 Pain assessment not documented as being performed, documentation the patient is not eligible for a pain assessment using a standardized tool
  • 2015 HCPCS G8447 TERMINATED 12/31/2012 : Patient encounter was documented using an ehr system that has been certified by an authorized testing and certification body (atcb)
  • 2015 HCPCS G8448 TERMINATED 12/31/2012 : Patient encounter was documented using a pqri qualified ehr or other acceptable systems
  • 2015 HCPCS G8450 Beta-blocker therapy prescribed
  • 2015 HCPCS G8451 Beta-blocker therapy for lvef < 40% not prescribed for reasons documented by the clinician (e.g., low blood pressure, fluid overload, asthma, patients recently treated with an intravenous positive inotropic agent, allergy, intolerance, other medical reaso
  • 2015 HCPCS G8452 Beta-blocker therapy not prescribed
  • 2015 HCPCS G8458 Clinician documented that patient is not an eligible candidate for genotype testing; patient not receiving antiviral treatment for hepatitis c
  • 2015 HCPCS G8459 TERMINATED 12/31/2013 : Clinician documented that patient is receiving antiviral treatment for hepatitis c
  • 2015 HCPCS G8460 Clinician documented that patient is not an eligible candidate for quantitative rna testing at week 12; patient not receiving antiviral treatment for hepatitis c
  • 2015 HCPCS G8461 Patient receiving antiviral treatment for hepatitis c during the measurement period
  • 2015 HCPCS G8462 TERMINATED 12/31/2013 : Clinician documented that patient is not an eligible candidate for counseling regarding contraception prior to antiviral treatment; patient not receiving antiviral treatment for hepatitis c
  • 2015 HCPCS G8463 TERMINATED 12/31/2013 : Patient receiving antiviral treatment for hepatitis c documented
  • 2015 HCPCS G8464 TERMINATED 12/31/2014 : Clinician documented that prostate cancer patient is not an eligible candidate for adjuvant hormonal therapy; low or intermediate risk of recurrence or risk of recurrence not determined
  • 2015 HCPCS G8465 High risk of recurrence of prostate cancer
  • 2015 HCPCS G8468 TERMINATED 12/31/2012 : Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescribed for patients with a left ventricular ejection fraction (lvef) <40% or documentation of moderately or severely depressed left ventricular systolic functi
  • 2015 HCPCS G8469 TERMINATED 12/31/2012 : Clinician documented that patient with a left ventricular ejection fraction (lvef) <40% or documentation of moderately or severely depressed left ventricular systolic function was not an eligible candidate for angiotensin converting enzyme (ace) inhibitor
  • 2015 HCPCS G8470 TERMINATED 12/31/2012 : Patient with left ventricular ejection fraction (lvef) >=40% or documentation as normal or mildly depressed left ventricular systolic function
  • 2015 HCPCS G8471 TERMINATED 12/31/2012 : Left ventricular ejection fraction (lvef) was not performed or documented
  • 2015 HCPCS G8472 TERMINATED 12/31/2012 : Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy not prescribed for patients with a left ventricular ejection fraction (lvef) <40% or documentation of moderately or severely depressed left ventricular systolic fu
  • 2015 HCPCS G8473 Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescribed
  • 2015 HCPCS G8474 Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy not prescribed for reasons documented by the clinician (eg, allergy, intolerance, pregnancy, renal failure due to ace inhibitor, diseases of the aortic or mitral v
  • 2015 HCPCS G8475 Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy not prescribed, reason not given
  • 2015 HCPCS G8476 Most recent blood pressure has a systolic measurement of < 140 mmhg and a diastolic measurement of < 90 mmhg
  • 2015 HCPCS G8477 Most recent blood pressure has a systolic measurement of >=140 mmhg and/or a diastolic measurement of >=90 mmhg
  • 2015 HCPCS G8478 Blood pressure measurement not performed or documented, reason not given
  • 2015 HCPCS G8482 Influenza immunization administered or previously received
  • 2015 HCPCS G8483 Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)
  • 2015 HCPCS G8484 Influenza immunization was not administered, reason not given
  • 2015 HCPCS G8485 I intend to report the diabetes mellitus (dm) measures group
  • 2015 HCPCS G8486 I intend to report the preventive care measures group
  • 2015 HCPCS G8487 I intend to report the chronic kidney disease (ckd) measures group
  • 2015 HCPCS G8489 I intend to report the coronary artery disease (cad) measures group
  • 2015 HCPCS G8490 I intend to report the rheumatoid arthritis (ra) measures group
  • 2015 HCPCS G8491 I intend to report the hiv/aids measures group
  • 2015 HCPCS G8492 TERMINATED 12/31/2014 : I intend to report the perioperative care measures group
  • 2015 HCPCS G8493 TERMINATED 12/31/2014 : I intend to report the back pain measures group
  • 2015 HCPCS G8494 All quality actions for the applicable measures in the diabetes mellitus (dm) measures group have been performed for this patient
  • 2015 HCPCS G8495 All quality actions for the applicable measures in the chronic kidney disease (ckd) measures group have been performed for this patient
  • 2015 HCPCS G8496 All quality actions for the applicable measures in the preventive care measures group have been performed for this patient
  • 2015 HCPCS G8497 All quality actions for the applicable measures in the coronary artery bypass graft (cabg) measures group have been performed for this patient
  • 2015 HCPCS G8498 All quality actions for the applicable measures in the coronary artery disease (cad) measures group have been performed for this patient
  • 2015 HCPCS G8499 All quality actions for the applicable measures in the rheumatoid arthritis (ra) measures group have been performed for this patient
  • 2015 HCPCS G8500 All quality actions for the applicable measures in the hiv/aids measures group have been performed for this patient
  • 2015 HCPCS G8501 TERMINATED 12/31/2014 : All quality actions for the applicable measures in the perioperative care measures group have been performed for this patient
  • 2015 HCPCS G8502 TERMINATED 12/31/2014 : All quality actions for the applicable measures in the back pain measures group have been performed for this patient
  • 2015 HCPCS G8506 Patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy
  • 2015 HCPCS G8508 TERMINATED 12/31/2011 : Documentation of pain assessment (including location, intensity and description) prior to initiation of therapy or documentation of the absence of pain as a result of assessment through discussion with the patient including the use of a standardized tool;
  • 2015 HCPCS G8509 Pain assessment documented as positive using a standardized tool, follow-up plan not documented, reason not given
  • 2015 HCPCS G8510 Screening for clinical depression is documented as negative, a follow-up plan is not required
  • 2015 HCPCS G8511 Screening for clinical depression documented as positive, follow up plan not documented, reason not given
  • 2015 HCPCS G8524 TERMINATED 12/31/2012 : Patch closure used for patient undergoing conventional cea
  • 2015 HCPCS G8525 TERMINATED 12/31/2012 : Clinician documented that patient did not receive conventional cea
  • 2015 HCPCS G8526 TERMINATED 12/31/2012 : Patch closure not used for patient undergoing conventional cea, reason not specified
  • 2015 HCPCS G8530 Autogenous av fistula received
  • 2015 HCPCS G8531 Clinician documented that patient was not an eligible candidate for autogenous av fistula
  • 2015 HCPCS G8532 Clinician documented that patient recevied vascular access other than autogenous av fistula, reason not given
  • 2015 HCPCS G8534 TERMINATED 12/31/2011 : Documentation of an elder maltreatment screen and follow-up plan
  • 2015 HCPCS G8535 Elder maltreatment screen not documented; documentation that patient not eligible for the elder maltreatment screen
  • 2015 HCPCS G8536 No documentation of an elder maltreatment screen, reason not given
  • 2015 HCPCS G8537 TERMINATED 12/31/2011 : Elder maltreatment screen documented, follow-up plan not documented, patient not eligible
  • 2015 HCPCS G8538 TERMINATED 12/31/2011 : Elder maltreatment screen documented, follow-up plan not documented, reason not specified
  • 2015 HCPCS G8539 Functional outcome assessment documented as positive using a standardized tool and a care plan based on identified deficiencies on the date of functional outcome assessment, is documented
  • 2015 HCPCS G8540 Functional outcome assessment not documented as being performed, documentation the patient is not eligible for a functional outcome assessment using a standardized tool
  • 2015 HCPCS G8541 Functional outcome assessment using a standardized tool not documented, reason not given
  • 2015 HCPCS G8542 Functional outcome assessment using a standardized tool is documented; no functional deficiencies identified, care plan not required
  • 2015 HCPCS G8543 Documentation of a positive functional outcome assessment using a standardized tool; care plan not documented, reason not given
  • 2015 HCPCS G8544 I intend to report the coronary artery bypass graft (cabg) measures group
  • 2015 HCPCS G8545 I intend to report the hepatitis c measures group
  • 2015 HCPCS G8546 TERMINATED 12/31/2012 : I intend to report the community-acquired pneumonia (cap) measures group
  • 2015 HCPCS G8547 TERMINATED 12/31/2014 : I intend to report the ischemic vascular disease (ivd) measures group
  • 2015 HCPCS G8548 I intend to report the heart failure (hf) measures group
  • 2015 HCPCS G8549 All quality actions for the applicable measures in the hepatitis c measures group have been performed for this patient
  • 2015 HCPCS G8550 TERMINATED 12/31/2012 : All quality actions for the applicable measures in the community-acquired pneumonia (cap) measures group have been performed for this patient
  • 2015 HCPCS G8551 All quality actions for the applicable measures in the heart failure (hf) measures group have been performed for this patient
  • 2015 HCPCS G8552 TERMINATED 12/31/2014 : All quality actions for the applicable measures in the ischemic vascular disease (ivd) measures group have been performed for this patient
  • 2015 HCPCS G8553 TERMINATED 12/31/2013 : Prescription(s) generated and transmitted via a qualified erx system
  • 2015 HCPCS G8556 TERMINATED 12/31/2013 : Referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation
  • 2015 HCPCS G8557 TERMINATED 12/31/2013 : Patient is not eligible for the referral for otologic evaluation measure
  • 2015 HCPCS G8558 TERMINATED 12/31/2013 : Not referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation, reason not given
  • 2015 HCPCS G8559 Patient referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation
  • 2015 HCPCS G8560 Patient has a history of active drainage from the ear within the previous 90 days
  • 2015 HCPCS G8561 Patient is not eligible for the referral for otologic evaluation for patients with a history of active drainage measure
  • 2015 HCPCS G8562 Patient does not have a history of active drainage from the ear within the previous 90 days
  • 2015 HCPCS G8563 Patient not referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation, reason not given
  • 2015 HCPCS G8564 Patient was referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation, reason not specified)
  • 2015 HCPCS G8565 Verification and documentation of sudden or rapidly progressive hearing loss
  • 2015 HCPCS G8566 Patient is not eligible for the "referral for otologic evaluation for sudden or rapidly progressive hearing loss" measure
  • 2015 HCPCS G8567 Patient does not have verification and documentation of sudden or rapidly progressive hearing loss
  • 2015 HCPCS G8568 Patient was not referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation, reason not given
  • 2015 HCPCS G8569 Prolonged postoperative intubation (> 24 hrs) required
  • 2015 HCPCS G8570 Prolonged postoperative intubation (> 24 hrs) not required
  • 2015 HCPCS G8571 Development of deep sternal wound infection/mediastinitis within 30 days postoperatively
  • 2015 HCPCS G8572 No deep sternal wound infection/mediastinitis
  • 2015 HCPCS G8573 Stroke following isolated cabg surgery
  • 2015 HCPCS G8574 No stroke following isolated cabg surgery
  • 2015 HCPCS G8575 Developed postoperative renal failure or required dialysis
  • 2015 HCPCS G8576 No postoperative renal failure/dialysis not required
  • 2015 HCPCS G8577 Re-exploration required due to mediastinal bleeding with or without tamponade, graft occlusion, valve dysfunction or other cardiac reason
  • 2015 HCPCS G8578 Re-exploration not required due to mediastinal bleeding with or without tamponade, graft occlusion, valve dysfunction or other cardiac reason
  • 2015 HCPCS G8579 TERMINATED 12/31/2014 : Antiplatelet medication at discharge
  • 2015 HCPCS G8580 TERMINATED 12/31/2014 : Antiplatelet medication contraindicated
  • 2015 HCPCS G8581 TERMINATED 12/31/2014 : No antiplatelet medication at discharge
  • 2015 HCPCS G8582 TERMINATED 12/31/2014 : Beta-blocker at discharge
  • 2015 HCPCS G8583 TERMINATED 12/31/2014 : Beta-blocker contraindicated
  • 2015 HCPCS G8584 TERMINATED 12/31/2014 : No beta-blocker at discharge
  • 2015 HCPCS G8585 TERMINATED 12/31/2014 : Anti-lipid treatment at discharge
  • 2015 HCPCS G8586 TERMINATED 12/31/2014 : Anti-lipid treatment contraindicated
  • 2015 HCPCS G8587 TERMINATED 12/31/2014 : No anti-lipid treatment at discharge
  • 2015 HCPCS G8588 TERMINATED 12/31/2013 : Most recent systolic blood pressure < 140 mmhg
  • 2015 HCPCS G8589 TERMINATED 12/31/2013 : Most recent systolic blood pressure >= 140 mmhg
  • 2015 HCPCS G8590 TERMINATED 12/31/2013 : Most recent diastolic blood pressure < 90 mmhg
  • 2015 HCPCS G8591 TERMINATED 12/31/2013 : Most recent diastolic blood pressure >= 90 mmhg
  • 2015 HCPCS G8592 TERMINATED 12/31/2013 : No documentation of blood pressure measurement, reason not given
  • 2015 HCPCS G8593 TERMINATED 12/31/2014 : Lipid profile results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c)
  • 2015 HCPCS G8594 TERMINATED 12/31/2014 : Lipid profile not performed, reason not given
  • 2015 HCPCS G8595 TERMINATED 12/31/2014 : Most recent ldl-c < 100 mg/dl
  • 2015 HCPCS G8596 TERMINATED 12/31/2013 : Ldl-c was not performed
  • 2015 HCPCS G8597 TERMINATED 12/31/2014 : Most recent ldl-c >= 100 mg/dl
  • 2015 HCPCS G8598 Aspirin or another antithrombotic therapy used
  • 2015 HCPCS G8599 Aspirin or another antithrombotic therapy not used, reason not given
  • 2015 HCPCS G8600 Iv t-pa initiated within three hours (<= 180 minutes) of time last known well
  • 2015 HCPCS G8601 Iv t-pa not initiated within three hours (<= 180 minutes) of time last known well for reasons documented by clinician
  • 2015 HCPCS G8602 Iv t-pa not initiated within three hours (<= 180 minutes) of time last known well, reason not given
  • 2015 HCPCS G8603 TERMINATED 12/31/2013 : Score on the spoken language comprehension functional communication measure at discharge was higher than at admission
  • 2015 HCPCS G8604 TERMINATED 12/31/2013 : Score on the spoken language comprehension functional communication measure at discharge was not higher than at admission, reason not given
  • 2015 HCPCS G8605 TERMINATED 12/31/2013 : Patient treated for spoken language comprehension but not scored on the spoken language comprehension functional communication measure either at admission or at discharge
  • 2015 HCPCS G8606 TERMINATED 12/31/2013 : Score on the attention functional communication measure at discharge was higher than at admission
  • 2015 HCPCS G8607 TERMINATED 12/31/2013 : Score on the attention functional communication measure at discharge was not higher than at admission, reason not given
  • 2015 HCPCS G8608 TERMINATED 12/31/2013 : Patient treated for attention but not scored on the attention functional communication measure either at admission or at discharge
  • 2015 HCPCS G8609 TERMINATED 12/31/2013 : Score on the memory functional communication measure at discharge was higher than at admission
  • 2015 HCPCS G8610 TERMINATED 12/31/2013 : Score on the memory functional communication measure at discharge was not higher than at admission, reason not given
  • 2015 HCPCS G8611 TERMINATED 12/31/2013 : Patient treated for memory but not scored on the memory functional communication measure either at admission or at discharge
  • 2015 HCPCS G8612 TERMINATED 12/31/2013 : Score on the motor speech functional communication measure at discharge was higher than at admission
  • 2015 HCPCS G8613 TERMINATED 12/31/2013 : Score on the motor speech functional communication measure at discharge was not higher than at admission, reason not given
  • 2015 HCPCS G8614 TERMINATED 12/31/2013 : Patient treated for motor speech but not scored on the motor speech comprehension functional communication measure either at admission or at discharge
  • 2015 HCPCS G8615 TERMINATED 12/31/2013 : Score on the reading functional communication measure at discharge was higher than at admission
  • 2015 HCPCS G8616 TERMINATED 12/31/2013 : Score on the reading functional communication measure at discharge was not higher than at admission, reason not given
  • 2015 HCPCS G8617 TERMINATED 12/31/2013 : Patient treated for reading but not scored on the reading functional communication measure either at admission or at discharge
  • 2015 HCPCS G8618 TERMINATED 12/31/2013 : Score on the spoken language expression functional communication measure at discharge was higher than at admission
  • 2015 HCPCS G8619 TERMINATED 12/31/2013 : Score on the spoken language expression functional communication measure at discharge was not higher than at admission, reason not given
  • 2015 HCPCS G8620 TERMINATED 12/31/2013 : Patient treated for spoken language expression but not scored on the spoken language expression functional communication measure either at admission or at discharge
  • 2015 HCPCS G8621 TERMINATED 12/31/2013 : Score on the writing functional communication measure at discharge was higher than at admission
  • 2015 HCPCS G8622 TERMINATED 12/31/2013 : Score on the writing functional communication measure at discharge was not higher than at admission, reason not given
  • 2015 HCPCS G8623 TERMINATED 12/31/2013 : Patient treated for writing but not scored on the writing functional communication measure either at admission or at discharge
  • 2015 HCPCS G8624 TERMINATED 12/31/2013 : Score on the swallowing functional communication measure at discharge was higher than at admission
  • 2015 HCPCS G8625 TERMINATED 12/31/2013 : Score on the swallowing functional communication measure at discharge was not higher than at admission, reason not given
  • 2015 HCPCS G8626 TERMINATED 12/31/2013 : Patient treated for swallowing but not scored on the swallowing functional communication measure at admission or at discharge
  • 2015 HCPCS G8627 Surgical procedure performed within 30 days following cataract surgery for major complications (e.g. retained nuclear fragments, endophthalmitis, dislocated or wrong power iol, retinal detachment, or wound dehiscence)
  • 2015 HCPCS G8628 Surgical procedure not performed within 30 days following cataract surgery for major complications (e.g. retained nuclear fragments, endophthalmitis, dislocated or wrong power iol, retinal detachment, or wound dehiscence)
  • 2015 HCPCS G8629 TERMINATED 12/31/2014 : Documentation of order for prophylactic parenteral antibiotic to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required)
  • 2015 HCPCS G8630 TERMINATED 12/31/2014 : Documentation that administration of prophylactic parenteral antibiotics was initiated within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required), as ordered
  • 2015 HCPCS G8631 TERMINATED 12/31/2014 : Clinician documented that patient was not an eligible candidate for ordering prophylactic parenteral antibiotics to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision i
  • 2015 HCPCS G8632 TERMINATED 12/31/2014 : Prophylactic parenteral antibiotics were not ordered to be given or given within one hour (if fluoroquinolone or vancomycin, two hours) prior to the surgical incision (or start of procedure when no incision is required), reason not given
  • 2015 HCPCS G8633 Pharmacologic therapy (other than minierals/vitamins) for osteoporosis prescribed
  • 2015 HCPCS G8634 Clinician documented patient not an eligible candidate to receive pharmacologic therapy for osteoporosis
  • 2015 HCPCS G8635 Pharmacologic therapy for osteoporosis was not prescribed, reason not given
  • 2015 HCPCS G8636 TERMINATED 12/31/2011 : Influenza immunization administered or previously received
  • 2015 HCPCS G8637 TERMINATED 12/31/2011 : Clinician documented that patient is not eligible to receive the influenza immunization
  • 2015 HCPCS G8638 TERMINATED 12/31/2011 : Influenza immunization not administered or previously received, reason not otherwise specified
  • 2015 HCPCS G8639 TERMINATED 12/31/2011 : Influenza immunization was administered or previously received
  • 2015 HCPCS G8640 TERMINATED 12/31/2011 : Clinician has documented that patient is not eligible to receive the influenza immunization
  • 2015 HCPCS G8641 TERMINATED 12/31/2011 : Influenza immunization was not administered or previously received, reason not otherwise specified
  • 2015 HCPCS G8642 TERMINATED 12/31/2013 : The eligible professional practices in a rural area without sufficient high speed internet access and requests a hardship exemption from the application of the payment adjustment under section 1848(a)(5)(a) of the social security act
  • 2015 HCPCS G8643 TERMINATED 12/31/2013 : The eligible professional practices in an area without sufficient available pharmacies for electronic prescribing and requests a hardship exemption for the application of the payment adjustment under section 1848(a)(5)(a) of the social security act
  • 2015 HCPCS G8644 TERMINATED 12/31/2013 : Eligible professional does not have prescribing privileges
  • 2015 HCPCS G8645 I intend to report the asthma measures group
  • 2015 HCPCS G8646 All quality actions for the applicable measures in the asthma measures group have been performed for this patient
  • 2015 HCPCS G8647 Risk-adjusted functional status change residual score for the knee successfully calculated and the score was equal to zero (0) or greater than zero (>0)
  • 2015 HCPCS G8648 Risk-adjusted functional status change residual score for the knee successfully calculated and the score was less than zero (<0)
  • 2015 HCPCS G8649 Risk-adjusted functional status change residual scores for the knee not measured because the patient did not complete foto's functional intake on admission and/or follow up status survey near discharge, patient not eligible/not appropriate
  • 2015 HCPCS G8650 Risk-adjusted functional status change residual scores for the knee not measured because the patient did not complete foto's functional intake on admission and/or follow up status survey near discharge, reason not given
  • 2015 HCPCS G8651 Risk-adjusted functional status change residual score for the hip successfully calculated and the score was equal to zero (0) or greater than zero (>0)
  • 2015 HCPCS G8652 Risk-adjusted functional status change residual score for the hip successfully calculated and the score was less than zero (<0)
  • 2015 HCPCS G8653 Risk-adjusted functional status change residual scores for the hip not measured because the patient did not complete foto's functional intake on admission and/or follow up status survey near discharge, patient not eligible/not appropriate
  • 2015 HCPCS G8654 Risk-adjusted functional status change residual scores for the hip not measured because the patient did not complete foto's functional intake on admission and/or follow up status survey near discharge, reason not given
  • 2015 HCPCS G8655 Risk-adjusted functional status change residual score for the lower leg, foot or ankle successfully calculated and the score was equal to zero (0) or greater than zero(>0)
  • 2015 HCPCS G8656 Risk-adjusted functional status change residual score for the lower leg, foot or ankle successfully calculated and the score was less than zero (<0)
  • 2015 HCPCS G8657 Risk-adjusted functional status change residual scores for the lower leg, foot or ankle not measured because the patient did not complete foto's functional intake on admission and/or follow up status survey near discharge, patient not eligible/not appropr
  • 2015 HCPCS G8658 Risk-adjusted functional status change residual scores for the lower leg, foot or ankle not measured because the patient did not complete foto's functional intake on admission and/or follow up status survey near discharge, reason not given
  • 2015 HCPCS G8659 Risk-adjusted functional status change residual score for the lumbar spine successfully calculated and the score was equal to zero (0) or greater than zero (>0)
  • 2015 HCPCS G8660 Risk-adjusted functional status change residual score for the lumbar spine successfully calculated and the score was less than zero (<0)
  • 2015 HCPCS G8661 Risk-adjusted functional status change residual scores for the lumbar spine not measured because the patient did not complete foto's functional intake on admission and/or follow up status survey near discharge, patient not eligible/not appropriate
  • 2015 HCPCS G8662 Risk-adjusted functional status change residual scores for the lumbar spine not measured because the patient did not complete foto's functional intake on admission and/or follow up status survey near discharge, reason not given
  • 2015 HCPCS G8663 Risk-adjusted functional status change residual score for the shoulder successfully calculated and the score was equal to zero (0) or greater than zero (>0)
  • 2015 HCPCS G8664 Risk-adjusted functional status change residual score for the shoulder successfully calculated and the score was less than zero (<0)
  • 2015 HCPCS G8665 Risk-adjusted functional status change residual scores for the shoulder not measured because the patient did not complete foto's functional intake on admission and/or follow up status survey near discharge, patient not eligible/not appropriate
  • 2015 HCPCS G8666 Risk-adjusted functional status change residual scores for the shoulder not measured because the patient did not complete foto's functional intake on admission and/or follow up status survey near discharge, reason not given
  • 2015 HCPCS G8667 Risk-adjusted functional status change residual score for the elbow, wrist or hand successfully calculated and the score was equal to zero (0) or greater than zero (>0)
  • 2015 HCPCS G8668 Risk-adjusted functional status change residual score for the elbow, wrist or hand successfully calculated and the score was less than zero (<0)
  • 2015 HCPCS G8669 Risk-adjusted functional status change residual scores for the elbow, wrist or hand not measured because the patient did not complete foto's functional intake on admission and/or follow up status survey near discharge, patient not eligible/not appropriate
  • 2015 HCPCS G8670 Risk-adjusted functional status change residual scores for the elbow, wrist or hand not measured because the patient did not complete foto's functional intake on admission and/or follow up status survey near discharge, reason not given
  • 2015 HCPCS G8671 Risk-adjusted functional status change residual score for the neck, cranium, mandible, thoracic spine, ribs, or other general orthopedic impairment successfully calculated and the score was equal to zero (0) or greater than zero (>0)
  • 2015 HCPCS G8672 Risk-adjusted functional status change residual score for the neck, cranium, mandible, thoracic spine, ribs, or other general orthopedic impairment successfully calculated and the score was less than zero (<0)
  • 2015 HCPCS G8673 Risk-adjusted functional status change residual scores for the neck, cranium, mandible, thoracic spine, ribs, or other general orthopedic impairment not measured because the patient did not complete foto's functional intake on admission and/or follow up s
  • 2015 HCPCS G8674 Risk-adjusted functional status change residual scores for the neck, cranium, mandible, thoracic spine, ribs, or other general orthopedic impairment not measured because the patient did not complete foto's functional intake on admission and/or follow up s
  • 2015 HCPCS G8675 TERMINATED 12/31/2012 : Most recent systolic blood pressure >= 140 mm hg
  • 2015 HCPCS G8676 TERMINATED 12/31/2012 : Most recent diastolic blood pressure >= 90 mm hg
  • 2015 HCPCS G8677 TERMINATED 12/31/2012 : Most recent systolic blood pressure < 130 mm hg
  • 2015 HCPCS G8678 TERMINATED 12/31/2012 : Most recent systolic blood pressure 130 to 139 mm hg
  • 2015 HCPCS G8679 TERMINATED 12/31/2012 : Most recent diastolic blood pressure < 80 mm hg
  • 2015 HCPCS G8680 TERMINATED 12/31/2012 : Most recent diastolic blood pressure 80 - 89 mm hg
  • 2015 HCPCS G8681 TERMINATED 12/31/2011 : Patient hospitalized with principal diagnosis of heart failure during the measurement period
  • 2015 HCPCS G8682 TERMINATED 12/31/2014 : Lvf testing documented as being performed prior to discharge or in the previous 12 months
  • 2015 HCPCS G8683 TERMINATED 12/31/2014 : Lvf testing not performed prior to discharge or in the previous 12 months for a medical or patient documented reason
  • 2015 HCPCS G8684 TERMINATED 12/31/2011 : Patient not hospitalized with principal diagnosis of heart failure during the measurement period
  • 2015 HCPCS G8685 TERMINATED 12/31/2014 : Lvf testing not documented as being performed prior to discharge or in the previous 12 months, reason not given
  • 2015 HCPCS G8686 TERMINATED 12/31/2011 : Currently a tobacco smoker or current exposure to secondhand smoke
  • 2015 HCPCS G8687 TERMINATED 12/31/2011 : Currently a tobacco non-user and no exposure to secondhand smoke
  • 2015 HCPCS G8688 TERMINATED 12/31/2011 : Currently a smokeless tobacco user (eg, chew, snuff) and no exposure to secondhand smoke
  • 2015 HCPCS G8689 TERMINATED 12/31/2011 : Tobacco use not assessed, reason not otherwise specified
  • 2015 HCPCS G8690 TERMINATED 12/31/2011 : Current tobacco smoker or current exposure to secondhand smoke
  • 2015 HCPCS G8691 TERMINATED 12/31/2011 : Current tobacco non-user and no exposure to secondhand smoke
  • 2015 HCPCS G8692 TERMINATED 12/31/2011 : Current smokeless tobacco user (eg, chew, snuff) and no exposure to secondhand smoke
  • 2015 HCPCS G8693 TERMINATED 12/31/2011 : Tobacco use not assessed, reason not specified
  • 2015 HCPCS G8694 Left ventriucular ejection fraction (lvef) < 40%
  • 2015 HCPCS G8695 TERMINATED 12/31/2012 : Left ventricular ejection fraction (lvef) >= 40% or documentation as mildly depressed left ventricular systolic function or normal
  • 2015 HCPCS G8696 Antithrombotic therapy prescribed at discharge
  • 2015 HCPCS G8697 Antithrombotic therapy not prescribed for documented reasons (e.g., patients admitted for performance of elective carotid intervention, patient had stroke during hospital stay, patient expired during inpatient stay, other medical reason(s)); (e.g., patien
  • 2015 HCPCS G8698 Antithrombotic therapy was not prescribed at discharge, reason not given
  • 2015 HCPCS G8699 TERMINATED 12/31/2014 : Rehabilitation services (occupational, physical or speech) ordered at or prior to discharge
  • 2015 HCPCS G8700 TERMINATED 12/31/2014 : Rehabilitation services (occupational, physical or speech) not indicated at or prior to discharge
  • 2015 HCPCS G8701 TERMINATED 12/31/2014 : Rehabilitation services were not ordered, reason not otherwise specified
  • 2015 HCPCS G8702 TERMINATED 12/31/2014 : Documentation that prophylactic antibiotics were given within 4 hours prior to surgical incision or intraoperatively
  • 2015 HCPCS G8703 TERMINATED 12/31/2014 : Documentation that prophylactic antibiotics were neither given within 4 hours prior to surgical incision nor intraoperatively
  • 2015 HCPCS G8704 TERMINATED 12/31/2014 : 12-lead electrocardiogram (ecg) performed
  • 2015 HCPCS G8705 TERMINATED 12/31/2014 : Documentation of medical reason(s) for not performing a 12-lead electrocardiogram (ecg)
  • 2015 HCPCS G8706 TERMINATED 12/31/2014 : Documentation of patient reason(s) for not performing a 12-lead electrocardiogram (ecg)
  • 2015 HCPCS G8707 TERMINATED 12/31/2014 : 12-lead electrocardiogram (ecg) not performed, reason not given
  • 2015 HCPCS G8708 Patient not prescribed or dispensed antibiotic
  • 2015 HCPCS G8709 Patient prescribed or dispensed antibiotic for documented medical reason(s) (e.g. intestinal infection, pertussis, bacterial infection, lyme disease, otitis media, acute sinusitis, acute pharyngitis, acute tonsillitis, chronic sinusitis, infection of the
  • 2015 HCPCS G8710 Patient prescribed or dispensed antibiotic
  • 2015 HCPCS G8711 Prescribed or dispensed antibiotic
  • 2015 HCPCS G8712 Antibiotic not prescribed or dispensed
  • 2015 HCPCS G8713 Spkt/v greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v])
  • 2015 HCPCS G8714 Hemodialysis treatment performed exactly three times per week for > 90 days
  • 2015 HCPCS G8715 TERMINATED 12/31/2012 : Hemodialysis treatment performed less than three times per week or greater than three times per week
  • 2015 HCPCS G8716 TERMINATED 12/31/2012 : Documentation of reason(s) for patient not having greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v])
  • 2015 HCPCS G8717 Spkt/v less than 1.2 (single-pool clearance of urea [kt] / volume [v]), reason not given
  • 2015 HCPCS G8718 Total kt/v greater than or equal to 1.7 per week (total clearance of urea [kt] / volume [v])
  • 2015 HCPCS G8720 Total kt/v less than 1.7 per week (total clearance of urea [kt] / volume [v])
  • 2015 HCPCS G8721 Pt category (primary tumor), pn category (regional lymph nodes), and histologic grade were documented in pathology report
  • 2015 HCPCS G8722 Documentation of medical reason(s) for not including the pt category, the pn category or the histologic grade in the pathology report (e.g., re-excision without residual tumor; non-carcinomasanal canal)
  • 2015 HCPCS G8723 Specimen site is other than anatomic location of primary tumor
  • 2015 HCPCS G8724 Pt category, pn category and histologic grade were not documented in the pathology report, reason not given
  • 2015 HCPCS G8725 Fasting lipid profile performed (triglycerides, ldl-c, hdl-c and total cholesterol)
  • 2015 HCPCS G8726 Clinician has documented reason for not performing fasting lipid profile (e.g., patient declined, other patient reasons)
  • 2015 HCPCS G8727 TERMINATED 12/31/2012 : Patient receiving hemodialysis, peritoneal dialysis or kidney transplantation
  • 2015 HCPCS G8728 Fasting lipid profile not performed, reason not given
  • 2015 HCPCS G8730 Pain assessment documented as positive using a standardized tool and a follow-up plan is documented
  • 2015 HCPCS G8731 Pain assessment using a standardized tool is documented as negative, no follow-up plan required
  • 2015 HCPCS G8732 No documentation of pain assessment, reason not given
  • 2015 HCPCS G8733 Elder maltreatment screen documented as positive and a follow-up plan is documented
  • 2015 HCPCS G8734 Elder maltreatment screen documented as negative, no follow-up required
  • 2015 HCPCS G8735 Elder maltreatment screen documented as positive, follow-up plan not documented, reason not given
  • 2015 HCPCS G8736 TERMINATED 12/31/2014 : Most current ldl-c <100mg/dl
  • 2015 HCPCS G8737 TERMINATED 12/31/2014 : Most current ldl-c >=100mg/dl
  • 2015 HCPCS G8738 TERMINATED 12/31/2014 : Left ventricular ejection fraction (lvef) < 40% or documentation of severely or moderately depressed left ventricular systolic function
  • 2015 HCPCS G8739 TERMINATED 12/31/2014 : Left ventricular ejection fraction (lvef) >= 40% or documentation as normal or mildly depressed left ventricular systolic function
  • 2015 HCPCS G8740 TERMINATED 12/31/2014 : Left ventricular ejection fraction (lvef) not performed or assessed, reason not given
  • 2015 HCPCS G8741 TERMINATED 12/31/2013 : Patient not treated for spoken language comprehension disorder
  • 2015 HCPCS G8742 TERMINATED 12/31/2013 : Patient not treated for attention disorder
  • 2015 HCPCS G8743 TERMINATED 12/31/2013 : Patient not treated for memory disorder
  • 2015 HCPCS G8744 TERMINATED 12/31/2013 : Patient not treated for motor speech disorder
  • 2015 HCPCS G8745 TERMINATED 12/31/2013 : Patient not treated for reading disorder
  • 2015 HCPCS G8746 TERMINATED 12/31/2013 : Patient not treated for spoken language expression disorder
  • 2015 HCPCS G8747 TERMINATED 12/31/2013 : Patient not treated for writing disorder
  • 2015 HCPCS G8748 TERMINATED 12/31/2013 : Patient not treated for swallowing disorder
  • 2015 HCPCS G8749 Absence of signs of melanoma (cough, dyspnea, tenderness, localized neurologic signs such as weakness, jaundice or any other sign suggesting systemic spread) or absence of symptoms of melanoma (pain, paresthesia, or any other symptom suggesting the possib
  • 2015 HCPCS G8750 TERMINATED 12/31/2012 : Presence of signs of melanoma (cough, dyspnea, tenderness, localized neurologic signs such as weakness, jaundice or any other sign suggesting systemic spread) or presence of symptoms of melanoma (pain, paresthesia, or any other symptom suggesting the poss
  • 2015 HCPCS G8751 TERMINATED 12/31/2014 : Smoking status and exposure to second hand smoke in the home not assessed, reason not given
  • 2015 HCPCS G8752 Most recent systolic blood pressure < 140mmhg
  • 2015 HCPCS G8753 Most recent systolic blood pressure >= 140mmhg
  • 2015 HCPCS G8754 Most recent diastolic blood pressure < 90mmhg
  • 2015 HCPCS G8755 Most recent diastolic blood pressure >= 90mmhg
  • 2015 HCPCS G8756 No documentation of blood pressure measurement, reason not given
  • 2015 HCPCS G8757 All quality actions for the applicable measures in the chronic obstructive pulmonary disease (copd) measures group have been performed for this patient
  • 2015 HCPCS G8758 All quality actions for the applicable measures in the inflammatory bowel disease (ibd) measures group have been performed for this patient
  • 2015 HCPCS G8759 All quality actions for the applicable measures in the sleep apnea measures group have been performed for this patient
  • 2015 HCPCS G8760 TERMINATED 12/31/2012 : All quality actions for the applicable measures in the epilepsy measures group have been performed for this patient
  • 2015 HCPCS G8761 All quality actions for the applicable measures in the dementia measures group have been performed for this patient
  • 2015 HCPCS G8762 All quality actions for the applicable measures in the parkinson's disease measures group have been performed for this patient
  • 2015 HCPCS G8763 TERMINATED 12/31/2014 : All quality actions for the applicable measures in the hypertension (htn) measures group have been performed for this patient
  • 2015 HCPCS G8764 TERMINATED 12/31/2014 : All quality actions for the applicable measures in the cardiovascular prevention measures group have bee performed for this patient
  • 2015 HCPCS G8765 All quality actions for the applicable measures in the cataract measures group have been performed for this patient
  • 2015 HCPCS G8767 TERMINATED 12/31/2014 : Lipid panel results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c)
  • 2015 HCPCS G8768 TERMINATED 12/31/2014 : Documentation of medical reason(s) for not performing lipid profile (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)
  • 2015 HCPCS G8769 TERMINATED 12/31/2014 : Lipid profile not performed, reason not given
  • 2015 HCPCS G8770 TERMINATED 12/31/2014 : Urine protein test result documented and reviewed
  • 2015 HCPCS G8771 TERMINATED 12/31/2014 : Documentation of diagnosis of chronic kidney disease
  • 2015 HCPCS G8772 TERMINATED 12/31/2014 : Documentation of medical reason(s) for not performing urine protein test (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not cllinically appropriate)
  • 2015 HCPCS G8773 TERMINATED 12/31/2014 : Urine protein test was not performed, reason not given
  • 2015 HCPCS G8774 TERMINATED 12/31/2014 : Serum creatinine test result documented and reviewed
  • 2015 HCPCS G8775 TERMINATED 12/31/2014 : Documentation of medical reason(s) for not performing serum creatinine test (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)
  • 2015 HCPCS G8776 TERMINATED 12/31/2014 : Serum creatinine test not performed, reason not given
  • 2015 HCPCS G8777 TERMINATED 12/31/2014 : Diabetes screening test performed
  • 2015 HCPCS G8778 TERMINATED 12/31/2014 : Documentation of medical reason(s) for not performing diabetes screening test (e.g., patients with a diagnosis of diabetes, or with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)
  • 2015 HCPCS G8779 TERMINATED 12/31/2014 : Diabetes screening test not performed, reason not given
  • 2015 HCPCS G8780 TERMINATED 12/31/2014 : Counseling for diet and physical activity performed
  • 2015 HCPCS G8781 TERMINATED 12/31/2014 : Documentation of medical reason(s) for patient not receiving counseling for diet and physical activity (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)
  • 2015 HCPCS G8782 TERMINATED 12/31/2014 : Counseling for diet and physical activity not performed, reason not given
  • 2015 HCPCS G8783 Normal blood pressure reading documented, follow-up not required
  • 2015 HCPCS G8784 Blood pressure reading not documented, documentation the patient is not eligible
  • 2015 HCPCS G8785 Blood pressure reading not documented, reason not given
  • 2015 HCPCS G8786 TERMINATED 12/31/2012 : Severity of angina assessed according to level of activity
  • 2015 HCPCS G8787 TERMINATED 12/31/2012 : Angina assessed as present
  • 2015 HCPCS G8788 TERMINATED 12/31/2012 : Angina assessed as absent
  • 2015 HCPCS G8789 TERMINATED 12/31/2012 : Severity of angina not assessed according to level of activity
  • 2015 HCPCS G8790 TERMINATED 12/31/2013 : Most recent office visit systolic blood pressure <130 mm hg
  • 2015 HCPCS G8791 TERMINATED 12/31/2013 : Most recent office visit systolic blood pressure, 130 to 139 mm hg
  • 2015 HCPCS G8792 TERMINATED 12/31/2013 : Most recent office visit systolic blood pressure >=140 mm hg
  • 2015 HCPCS G8793 TERMINATED 12/31/2013 : Most recent office visit diastolic blood pressure, <80 mm hg
  • 2015 HCPCS G8794 TERMINATED 12/31/2013 : Most recent office visit diastolic blood pressure, 80 - 89 mm hg
  • 2015 HCPCS G8795 TERMINATED 12/31/2013 : Most recent office visit diastolic blood pressure >=90 mm hg
  • 2015 HCPCS G8796 TERMINATED 12/31/2013 : Blood pressure measurement not documented, reason not given
  • 2015 HCPCS G8797 Specimen site other than anatomic location of esophagus
  • 2015 HCPCS G8798 Specimen site other than anatomic location of prostate
  • 2015 HCPCS G8799 TERMINATED 12/31/2013 : Anticoagulation ordered
  • 2015 HCPCS G8800 TERMINATED 12/31/2013 : Anticoagulation not ordered for reasons documented by clinician
  • 2015 HCPCS G8801 TERMINATED 12/31/2013 : Anticoagulation was not ordered, reason not given
  • 2015 HCPCS G8802 TERMINATED 12/31/2012 : Pregnancy test (urine or serum) ordered
  • 2015 HCPCS G8803 TERMINATED 12/31/2012 : Pregnancy test (urine or serum) not ordered for reasons documented by clinician
  • 2015 HCPCS G8805 TERMINATED 12/31/2012 : Pregnancy test (urine or serum) was not ordered, reason not specified
  • 2015 HCPCS G8806 Performance of trans-abdominal or trans-vaginal ultrasound
  • 2015 HCPCS G8807 Trans-abdominal or trans-vaginal ultrasound not performed for reasons documented by clinician (e.g., patient has visited the ed multiple times within 72 hours, patient has a documented intrauterine pregnancy [iup])
  • 2015 HCPCS G8808 Performance of trans-abdominal or trans-vaginal ultrasound not ordered, reason not given (e.g., patient has visited the ed multiple times with no documentation of a trans-abdominal or trans-vaginal ultrasound within ed or from referring eligible professio
  • 2015 HCPCS G8809 Rh-immunoglobulin (rhogam) ordered
  • 2015 HCPCS G8810 Rh-immunoglobulin (rhogam) not ordered for reasons documented by clinician (e.g., patient had prior documented receipt of rhogam within 12 weeks, patient refusal)
  • 2015 HCPCS G8811 Documentation rh-immunoglobulin (rhogam) was not ordered, reason not given
  • 2015 HCPCS G8812 TERMINATED 12/31/2013 : Patient is not eligible for follow-up cta, duplex, or mra (e.g., patient death, failure to return for scheduled follow-up exam, planned follow-up study which will meet numerator criteria has not yet occurred at the time of reporting)
  • 2015 HCPCS G8813 TERMINATED 12/31/2013 : Follow-up cta, duplex, or mra of the abdomen and pelvis performed
  • 2015 HCPCS G8814 TERMINATED 12/31/2013 : Follow-up cta, duplex, or mra of the abdomen and pelvis not performed
  • 2015 HCPCS G8815 Statin therapy not prescribed for documented reasons (e.g., medical intolerance to statin, death of patient prior to discharge, transfer of care to another acute care or federal hospital, hospice admission, left against medical advice)
  • 2015 HCPCS G8816 Statin medication prescribed at discharge
  • 2015 HCPCS G8817 Statin therapy not prescribed at discharge, reason not given
  • 2015 HCPCS G8818 Patient discharge to home no later than post-operative day #7
  • 2015 HCPCS G8819 TERMINATED 12/31/2012 : Aneurysm minor diameter <= 5.5 cm
  • 2015 HCPCS G8820 TERMINATED 12/31/2012 : Aneurysm minor diameter 5.6-6.0 cm
  • 2015 HCPCS G8821 TERMINATED 12/31/2012 : Abdominal aortic aneurysm is not infarenal
  • 2015 HCPCS G8822 TERMINATED 12/31/2012 : Male patients with aneurysms minor diameter >6 cm
  • 2015 HCPCS G8823 TERMINATED 12/31/2012 : Female patients with aneurysm minor diameter >6cm
  • 2015 HCPCS G8824 TERMINATED 12/31/2012 : Female patients with aneurysm minor diameter 5.6-6.0 cm
  • 2015 HCPCS G8825 Patient not discharged to home by post-operative day #7
  • 2015 HCPCS G8826 Patient discharge to home no later than post-operative day #2 following evar
  • 2015 HCPCS G8827 TERMINATED 12/31/2013 : Aneurysm minor diameter <= 5.5 cm for women
  • 2015 HCPCS G8828 TERMINATED 12/31/2012 : Aneurysm minor diameter <= 5.5 cm for men
  • 2015 HCPCS G8829 TERMINATED 12/31/2012 : Aneurysm minor diameter 5.6-6.0 cm for men
  • 2015 HCPCS G8830 TERMINATED 12/31/2012 : Aneurysm minor diameter >6cm for men
  • 2015 HCPCS G8831 TERMINATED 12/31/2012 : Aneurysm minor diameter >6cm for women
  • 2015 HCPCS G8832 TERMINATED 12/31/2012 : Aneurysm minor diameter 5.6-6.0 cm for women
  • 2015 HCPCS G8833 Patient not discharged to home by post-operative day #2 following evar
  • 2015 HCPCS G8834 Patient discharged to home no later than post-operative day #2 following cea
  • 2015 HCPCS G8835 TERMINATED 12/31/2013 : Asymptomatic patient with no history of any transient ischemic attack or stroke in any carotid or vertebrobasilar territory
  • 2015 HCPCS G8836 TERMINATED 12/31/2012 : Symptomatic patient with ipsilateral stroke or tia within 120 days prior to cea
  • 2015 HCPCS G8837 TERMINATED 12/31/2012 : Other symptomatic patient with ipsilateral carotid territory tia or stroke > 120 days prior to cea, or contralateral carotid territory tia or stroke or vertebrobasilar tia or stroke
  • 2015 HCPCS G8838 Patient not discharged to home by post-operative day #2 following cea
  • 2015 HCPCS G8839 Sleep apnea symptoms assessed, including presence or absence of snoring and daytime sleepiness
  • 2015 HCPCS G8840 Documentation of reason(s) for not documenting an assessment of sleep symptoms (e.g., patient didn't have initial daytime sleepiness, patient visited between initial testing and initiation of therapy)
  • 2015 HCPCS G8841 Sleep apnea symptoms not assessed, reason not given
  • 2015 HCPCS G8842 Apnea hypopnea index (ahi) or respiratory disturbance index (rdi) measured at the time of initial diagnosis
  • 2015 HCPCS G8843 Documentation of reason(s) for not measuring an apnea hypopnea index (ahi) or a respiratory disturbance index (rdi) at the time of initial diagnosis (e.g., psychiatric disease, dementia, patient declined, financial, insurance coverage, test ordered but no
  • 2015 HCPCS G8844 Apnea hypopnea index (ahi) or respiratory disturbance index (rdi) not measured at the time of initial diagnosis, reason not given
  • 2015 HCPCS G8845 Positive airway pressure therapy prescribed
  • 2015 HCPCS G8846 Moderate or severe obstructive sleep apnea (apnea hypopnea index (ahi) or respiratory disturbance index (rdi) of 15 or greater)
  • 2015 HCPCS G8847 TERMINATED 12/31/2012 : Positive airway pressure therapy not prescribed
  • 2015 HCPCS G8848 Mild obstructive sleep apnea (apnea hypopnea index (ahi) or respiratory disturbance index (rdi) of less than 15)
  • 2015 HCPCS G8849 Documentation of reason(s) for not prescribing positive airway pressure therapy (e.g., patient unable to tolerate, alternative therapies use, patient declined, financial, insurance coverage)
  • 2015 HCPCS G8850 Positive airway pressure therapy not prescribed, reason not given
  • 2015 HCPCS G8851 Objective measurement of adherence to positive airway pressure therapy, documented
  • 2015 HCPCS G8852 Positive airway pressure therapy prescribed
  • 2015 HCPCS G8853 Positive airway pressure therapy not prescribed
  • 2015 HCPCS G8854 Documentation of reason(s) for not objectively measuring adherence to positive airway pressure therapy (e.g., patient didn't bring data from continous positive airway pressure [cpap], therapy not yet initiated, not available on machine)
  • 2015 HCPCS G8855 Objective measurement of adherence to positive airway pressure therapy not performed, reason not given
  • 2015 HCPCS G8856 Referral to a physician for an otologic evaluation performed
  • 2015 HCPCS G8857 Patient is not eligible for the referral for otologic evaluation measure (e.g., patients who are already under the care of a physician for acute or chronic dizziness)
  • 2015 HCPCS G8858 Referral to a physician for an otologic evaluation not performed, reason not given
  • 2015 HCPCS G8859 TERMINATED 12/31/2014 : Patient receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days
  • 2015 HCPCS G8860 TERMINATED 12/31/2014 : Patients who have received dose of corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days
  • 2015 HCPCS G8861 Within the past 2 years, central dual-energy x-ray absorptiometry (dxa) ordered and documented, review of systems and medication history or pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribed
  • 2015 HCPCS G8862 TERMINATED 12/31/2014 : Patients not receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days
  • 2015 HCPCS G8863 Patients not assessed for risk of bone loss, reason not given
  • 2015 HCPCS G8864 Pneumococcal vaccine administered or previously received
  • 2015 HCPCS G8865 Documentation of medical reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient allergic reaction, potential adverse drug reaction)
  • 2015 HCPCS G8866 Documentation of patient reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient refusal)
  • 2015 HCPCS G8867 Pneumococcal vaccine not administered or previously received, reason not given
  • 2015 HCPCS G8868 Patients receiving a first course of anti-tnf therapy
  • 2015 HCPCS G8869 Patient has documented immunity to hepatitis b and is receiving a first course of anti-tnf therapy
  • 2015 HCPCS G8870 Hepatitis b vaccine injection administered or previously received and is receiving a first course of anti-tnf therapy
  • 2015 HCPCS G8871 Patient not receiving a first course of anti-tnf therapy
  • 2015 HCPCS G8872 Excised tissue evaluated by imaging intraoperatively to confirm successful inclusion of targeted lesion
  • 2015 HCPCS G8873 Patients with needle localization specimens which are not amenable to intraoperative imaging such as mri needle wire localization, or targets which are tentatively identified on mammogram or ultrasound which do not contain a biopsy marker but which can be
  • 2015 HCPCS G8874 Excised tissue not evaluated by imaging intraoperatively to confirm successful inclusion of targeted lesion
  • 2015 HCPCS G8875 Clinician diagnosed breast cancer preoperatively by a minimally invasive biopsy method
  • 2015 HCPCS G8876 Documentation of reason(s) for not performing minimally invasive biopsy to diagnose breast cancer properatively (e.g., lesion too close to skin, implant, chest wall, etc., lesion could not be adequately visualized for needle biopsy, patient condition prev
  • 2015 HCPCS G8877 Clinician did not attempt to achieve the diagnosis of breast cancer preoperatively by a minimally invasive biopsy method, reason not given
  • 2015 HCPCS G8878 Sentinel lymph node biopsy procedure performed
  • 2015 HCPCS G8879 Clinically node negative (t1n0m0) or t2n0m0) invasive breast cancer
  • 2015 HCPCS G8880 Documentation of reason(s) sentinel lymph node biopsy not performed (e.g., reasons could include but not limited to; non-invasive cancer, incidental discovery of breast cancer on prophylactic mastectomy, incidental discovery of breast cancer on reduction
  • 2015 HCPCS G8881 Stage of breast cancer is greater than t1n0m0 or t2n0m0
  • 2015 HCPCS G8882 Sentinel lymph node biopsy procedure not performed, reason not given
  • 2015 HCPCS G8883 Biopsy results reviewed, communicated, tracked and documented
  • 2015 HCPCS G8884 Clinician documented reason that patient's biopsy results were not reviewed
  • 2015 HCPCS G8885 Bipsy results not reviewed, communicated, tracked or documented
  • 2015 HCPCS G8886 TERMINATED 12/31/2014 : Most recent blood pressure under control
  • 2015 HCPCS G8887 TERMINATED 12/31/2014 : Documentation of medical reason(s) for most recent blood pressure not being under control (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)
  • 2015 HCPCS G8888 TERMINATED 12/31/2014 : Most recent blood pressure not under control, results documented and reviewed
  • 2015 HCPCS G8889 TERMINATED 12/31/2014 : No documentation of blood pressure measurement, reason not given
  • 2015 HCPCS G8890 TERMINATED 12/31/2014 : Most recent ldl-c under control, results documented and reviewed
  • 2015 HCPCS G8891 TERMINATED 12/31/2014 : Documentation of medical reason(s) for most recent ldl-c not under control (e.g., patients with palliative goals for for whom treatment of hypertension with standard treatment goals is not clinically appropriate)
  • 2015 HCPCS G8892 TERMINATED 12/31/2014 : Documentation of medical reason(s) for not performing ldl-c test (e.g. patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)
  • 2015 HCPCS G8893 TERMINATED 12/31/2014 : Most recent ldl-c not under control, results documented and reviewed
  • 2015 HCPCS G8894 TERMINATED 12/31/2014 : Ldl-c not performed, reason not given
  • 2015 HCPCS G8895 TERMINATED 12/31/2014 : Oral aspirin or other antithrombotic therapy prescribed
  • 2015 HCPCS G8896 TERMINATED 12/31/2014 : Documentation of medical reason(s) for not prescribing oral aspirin or other antthrombotic therapy (e.g., patient documented to be low risk or patient with terminal illness or treatment of hypertension with standard treatment goals is not clinically appro
  • 2015 HCPCS G8897 TERMINATED 12/31/2014 : Oral aspirin or other antithrombotic therapy was not prescribed, reason not given
  • 2015 HCPCS G8898 I intend to report the chronic obstructive pulmonary disease (copd) measures group
  • 2015 HCPCS G8899 I intend to report the inflammatory bowel disease (ibd) measures group
  • 2015 HCPCS G8900 I intend to report the sleep apnea measures group
  • 2015 HCPCS G8901 TERMINATED 12/31/2012 : I intend to report the epilepsy measures group
  • 2015 HCPCS G8902 I intend to report the dementia measures group
  • 2015 HCPCS G8903 I intend to report the parkinson's disease measures group
  • 2015 HCPCS G8904 TERMINATED 12/31/2014 : I intend to report the hypertension (htn) measures group
  • 2015 HCPCS G8905 TERMINATED 12/31/2014 : I intend to report the cardiovascular prevention measures group
  • 2015 HCPCS G8906 I intend to report the cataract measures group
  • 2015 HCPCS G8907 Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer or hospital admission upon discharge from the facility
  • 2015 HCPCS G8908 Patient documented to have received a burn prior to discharge
  • 2015 HCPCS G8909 Patient documented not to have received a burn prior to discharge
  • 2015 HCPCS G8910 Patient documented to have experienced a fall within asc
  • 2015 HCPCS G8911 Patient documented not to have experienced a fall within ambulatory surgical center
  • 2015 HCPCS G8912 Patient documented to have experienced a wrong site, wrong side, wrong patient, wrong procedure or wrong implant event
  • 2015 HCPCS G8913 Patient documented not to have experienced a wrong site, wrong side, wrong patient, wrong procedure or wrong implant event
  • 2015 HCPCS G8914 Patient documented to have experienced a hospital transfer or hospital admission upon discharge from asc
  • 2015 HCPCS G8915 Patient documented not to have experienced a hospital transfer or hospital admission upon discharge from asc
  • 2015 HCPCS G8916 Patient with preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis, antibiotic initiated on time
  • 2015 HCPCS G8917 Patient with preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis, antibiotic not initiated on time
  • 2015 HCPCS G8918 Patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis
  • 2015 HCPCS G8919 TERMINATED 12/31/2013 : Most recent systolic blood pressure < 140 mmhg
  • 2015 HCPCS G8920 TERMINATED 12/31/2013 : Most recent systolic blood pressure >= 140 mmhg
  • 2015 HCPCS G8921 TERMINATED 12/31/2013 : Most recent diastolic blood pressure < 90 mmhg
  • 2015 HCPCS G8922 TERMINATED 12/31/2013 : Most recent diastolic blood pressure >= 90 mmhg
  • 2015 HCPCS G8923 Left ventricular ejection fraction (lvef) < 40% or documentation of moderately or severely depressed left ventricular systolic function
  • 2015 HCPCS G8924 Spirometry test results demonstrate fev1/fvc < 60% and patient has copd symptoms (e.g., dyspnea, cough/sputum, wheezing)
  • 2015 HCPCS G8925 Spirometry test results demonstrate fev1/fvc >=60% or patient does not have copd symptoms
  • 2015 HCPCS G8926 Spirometry test not performed or documented, reason not given
  • 2015 HCPCS G8927 Adjuvant chemotherapy referred, prescribed or previously received for ajcc stage iii, colon cancer
  • 2015 HCPCS G8928 Adjuvant chemotherapy not prescribed or previously received for documented reasons (e.g., medical co-morbidities, diagnosis date more than 5 years prior to the current visit date, patient's cancer has metastasized, medical contraindication/allergy, poor p
  • 2015 HCPCS G8929 Adjuvant chemotherapy not prescribed or previously received, reason not specified
  • 2015 HCPCS G8930 TERMINATED 12/31/2014 : Assessment of depression severity at the initial evaluation
  • 2015 HCPCS G8931 TERMINATED 12/31/2014 : Assessment of depression severity not documented, reason not given
  • 2015 HCPCS G8932 TERMINATED 12/31/2014 : Suicide risk assessed at the initial evaluation
  • 2015 HCPCS G8933 TERMINATED 12/31/2014 : Suicide risk not assessed at the initial evaluation, reason not given
  • 2015 HCPCS G8934 Left ventricular ejection fraction (lvef) <40% or documentation of moderately or severely depressed left ventricular systolic function
  • 2015 HCPCS G8935 Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy
  • 2015 HCPCS G8936 Clinician documented that patient was not an eligible candidate for angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy (eg, allergy, intolerance, pregnancy, renal failure due to ace inhibitor, diseases of the aorti
  • 2015 HCPCS G8937 Clinician did not prescribe angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy, reason not given
  • 2015 HCPCS G8938 Bmi is documented as being outside of normal limits, follow-up plan is not documented, documentation the patient is not eligible
  • 2015 HCPCS G8939 Pain assessment documented as positive, follow-up plan not documented, documentation the patient is not eligible
  • 2015 HCPCS G8940 Screening for clinical depression documented as positive, a follow-up plan not documented, documentation stating the patient is not eligible
  • 2015 HCPCS G8941 Elder maltreatment screen documented as positive, follow-up plan not documented, documentation the patient is not eligible
  • 2015 HCPCS G8942 Functional outcomes assessment using a standardized tool is documented within the previous 30 days and care plan, based on identified deficiencies on the date of the functional outcome assessment, is documented
  • 2015 HCPCS G8943 TERMINATED 12/31/2014 : Ldl-c result not present or not within 12 months prior
  • 2015 HCPCS G8944 Ajcc melanoma cancer stage 0 through iic melanoma
  • 2015 HCPCS G8945 TERMINATED 12/31/2013 : Aneurysm minor diameter <= 6 cm for men
  • 2015 HCPCS G8946 Minimally invasive biopsy method attempted but not diagnostic of breast cancer (e.g., high risk lesion of breast such as atypical ductal hyperplasia, lobular neoplasia, atypical lobular hyperplasia, lobular carcinoma in situ, atypical columnar hyperplasic
  • 2015 HCPCS G8947 One or more neuropsychiatric symptoms
  • 2015 HCPCS G8948 No neuropsychiatric symptoms
  • 2015 HCPCS G8949 TERMINATED 12/31/2014 : Documentation of patient reason(s) for patient not receiving counseling for diet and physical activity (e.g., patient is not willing to discuss diet or exercise interventions to help control blood pressure, or the patient said he/she refused to make these
  • 2015 HCPCS G8950 Pre-hypertensive or hypertensive blood pressure reading documented, and the indicated follow-up is documented
  • 2015 HCPCS G8951 Pre-hypertensive or hypertensive blood pressure reading documented, indicated follow-up not documented, documentation the patient is not eligible
  • 2015 HCPCS G8952 Pre-hypertensive or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given
  • 2015 HCPCS G8953 All quality actions for the applicable measures in the oncology measures group have been performed for this patient
  • 2015 HCPCS G8954 TERMINATED 12/31/2013 : Complete and appropriate patient data were reported to a qualified clinical database registry
  • 2015 HCPCS G8955 Most recent assessment of adequacy of volume management
  • 2015 HCPCS G8956 Patient receiving maintenance hemodialysis in an outpatient dialysis facility
  • 2015 HCPCS G8957 TERMINATED 12/31/2014 : Patient not receiving maintenance hemodialysis in an outpatient dialysis facility
  • 2015 HCPCS G8958 Assessment of adequacy of volume management not documented, reason not given
  • 2015 HCPCS G8959 Clinician treating major depressive disorder communicates to clinician treating comorbid condition
  • 2015 HCPCS G8960 Clinician treating major depressive disorder did not communicate to clinician treating comorbid condition, reason not given
  • 2015 HCPCS G8961 Cardiac stress imaging test primarily performed on low-risk surgery patient for preoperative evaluation within 30 days preceding this surgery
  • 2015 HCPCS G8962 Cardiac stress imaging test performed on patient for any reason including those who did not have low risk surgery or test that was performed more than 30 days preceding low risk surgery
  • 2015 HCPCS G8963 Cardiac stress imaging performed primarily for monitoring of asymptomatic patient who had pci within 2 years
  • 2015 HCPCS G8964 Cardiac stress imaging test performed primarily for any other reason than monitoring of asymptomatic patient who had pci within 2 years (e.g., symptomatic patient, patient greater than 2 years since pci, initial evaluation, etc)
  • 2015 HCPCS G8965 Cardiac stress imaging test primarily performed on low chd risk patient for initial detection and risk assessment
  • 2015 HCPCS G8966 Cardiac stress imaging test performed on symptomatic or higher than low chd risk patient or for any reason other than initial detection and risk assessment
  • 2015 HCPCS G8967 Warfarin or another oral anticoagulant that is fda approved prescribed
  • 2015 HCPCS G8968 Documentation of medical reason(s) for not prescribing warfarin or another oral anticoagulant that is fda approved for the prevention of thromboembolism [eg, patients with mitral stenosis or prosthetic heart valves, patients with transient or reversible c
  • 2015 HCPCS G8969 Documentation of patient reason(s) for not prescribing warfarin or another oral anticoagulant that is fda approved (e.g., economic, social, and/or religious impediments, noncompliance patient refusal, other patient reasons)
  • 2015 HCPCS G8970 No risk factors or one moderate risk factor for thromboembolism
  • 2015 HCPCS G8971 Warfarin or another oral anticoagulant that is fda approved not prescribed, reason not given
  • 2015 HCPCS G8972 One or more high risk factors for thromboembolism or more than one moderate risk factor for thromboembolism
  • 2015 HCPCS G8973 Most recent hemoglobin (hgb) level < 10 g/dl
  • 2015 HCPCS G8974 Hemoglobin level measurement not documented, reason not given
  • 2015 HCPCS G8975 Documentation of medical reason(s) for patient having a hemoglobin level < 10 g/dl (e.g., patients who have non-renal etiologies of anemia [e.g., sickle cell anemia or other hemoglobinopathies, hypersplenism, primary bone marrow disease, anemia related to
  • 2015 HCPCS G8976 Most recent hemoglobin (hgb) level >= 10 g/dl
  • 2015 HCPCS G8977 I intend to report the oncology measures group
  • 2015 HCPCS G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals
  • 2015 HCPCS G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting
  • 2015 HCPCS G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting
  • 2015 HCPCS G8981 Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals
  • 2015 HCPCS G8982 Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting
  • 2015 HCPCS G8983 Changing & maintaining body position functional limitation, discharge status, at discharge from therapy or to end reporting
  • 2015 HCPCS G8984 Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals
  • 2015 HCPCS G8985 Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting
  • 2015 HCPCS G8986 Carrying, moving & handling objects functional limitation, discharge status, at discharge from therapy or to end reporting
  • 2015 HCPCS G8987 Self care functional limitation, current status, at therapy episode outset and at reporting intervals
  • 2015 HCPCS G8988 Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting
  • 2015 HCPCS G8989 Self care functional limitation, discharge status, at discharge from therapy or to end reporting
  • 2015 HCPCS G8990 Other physical or occupational therapy primary functional limitation, current status, at therapy episode outset and at reporting intervals
  • 2015 HCPCS G8991 Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting
  • 2015 HCPCS G8992 Other physical or occupational therapy primary functional limitation, discharge status, at discharge from therapy or to end reporting
  • 2015 HCPCS G8993 Other physical or occupational therapy subsequent functional limitation, current status, at therapy episode outset and at reporting intervals
  • 2015 HCPCS G8994 Other physical or occupational therapy subsequent functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting
  • 2015 HCPCS G8995 Other physical or occupational therapy subsequent functional limitation, discharge status, at discharge from therapy or to end reporting
  • 2015 HCPCS G8996 Swallowing functional limitation, current status at therapy episode outset and at reporting intervals
  • 2015 HCPCS G8997 Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting
  • 2015 HCPCS G8998 Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting
  • 2015 HCPCS G8999 Motor speech functional limitation, current status at therapy episode outset and at reporting intervals
  • 2015 HCPCS G9001 Coordinated care fee, initial rate
  • 2015 HCPCS G9002 Coordinated care fee, maintenance rate
  • 2015 HCPCS G9003 Coordinated care fee, risk adjusted high, initial
  • 2015 HCPCS G9004 Coordinated care fee, risk adjusted low, initial
  • 2015 HCPCS G9005 Coordinated care fee, risk adjusted maintenance
  • 2015 HCPCS G9006 Coordinated care fee, home monitoring
  • 2015 HCPCS G9007 Coordinated care fee, scheduled team conference
  • 2015 HCPCS G9008 Coordinated care fee, physician coordinated care oversight services
  • 2015 HCPCS G9009 Coordinated care fee, risk adjusted maintenance, level 3
  • 2015 HCPCS G9010 Coordinated care fee, risk adjusted maintenance, level 4
  • 2015 HCPCS G9011 Coordinated care fee, risk adjusted maintenance, level 5
  • 2015 HCPCS G9012 Other specified case management service not elsewhere classified
  • 2015 HCPCS G9013 Esrd demo basic bundle level i
  • 2015 HCPCS G9014 Esrd demo expanded bundle including venous access and related services
  • 2015 HCPCS G9016 Smoking cessation counseling, individual, in the absence of or in addition to any other evaluation and management service, per session (6-10 minutes) [demo project code only]
  • 2015 HCPCS G9017 Amantadine hydrochloride, oral, per 100 mg (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9018 Zanamivir, inhalation powder, administered through inhaler, per 10 mg (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9019 Oseltamivir phosphate, oral, per 75 mg (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9020 Rimantadine hydrochloride, oral, per 100 mg (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9033 Amantadine hydrochloride, oral brand, per 100 mg (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9034 Zanamivir, inhalation powder, administered through inhaler, brand, per 10 mg (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9035 Oseltamivir phosphate, oral, brand, per 75 mg (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9036 Rimantadine hydrochloride, oral, brand, per 100 mg (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9041 TERMINATED 12/31/2011 : Rehabilitation services for low vision by qualified occupational therapist, direct one-on-one contact, each 15 minutes
  • 2015 HCPCS G9042 TERMINATED 12/31/2011 : Rehabilitation services for low vision by certified orientation and mobility specialists, direct one-on-one contact, each 15 minutes
  • 2015 HCPCS G9043 TERMINATED 12/31/2011 : Rehabilitation services for low vision by certified low vision rehabilitation therapist, direct one-on-one contact, each 15 minutes
  • 2015 HCPCS G9044 TERMINATED 12/31/2011 : Rehabilitation services for low vision by certified low vision rehabilitation teacher, direct one-on-one contact, each 15 minutes
  • 2015 HCPCS G9050 Oncology; primary focus of visit; work-up, evaluation, or staging at the time of cancer diagnosis or recurrence (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9051 Oncology; primary focus of visit; treatment decision-making after disease is staged or restaged, discussion of treatment options, supervising/coordinating active cancer directed therapy or managing consequences of cancer directed therapy (for use in a med
  • 2015 HCPCS G9052 Oncology; primary focus of visit; surveillance for disease recurrence for patient who has completed definitive cancer-directed therapy and currently lacks evidence of recurrent disease; cancer directed therapy might be considered in the future (for use in
  • 2015 HCPCS G9053 Oncology; primary focus of visit; expectant management of patient with evidence of cancer for whom no cancer directed therapy is being administered or arranged at present; cancer directed therapy might be considered in the future (for use in a medicare-ap
  • 2015 HCPCS G9054 Oncology; primary focus of visit; supervising, coordinating or managing care of patient with terminal cancer or for whom other medical illness prevents further cancer treatment; includes symptom management, end-of-life care planning, management of palliat
  • 2015 HCPCS G9055 Oncology; primary focus of visit; other, unspecified service not otherwise listed (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9056 Oncology; practice guidelines; management adheres to guidelines (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9057 Oncology; practice guidelines; management differs from guidelines as a result of patient enrollment in an institutional review board approved clinical trial (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9058 Oncology; practice guidelines; management differs from guidelines because the treating physician disagrees with guideline recommendations (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9059 Oncology; practice guidelines; management differs from guidelines because the patient, after being offered treatment consistent with guidelines, has opted for alternative treatment or management, including no treatment (for use in a medicare-approved demo
  • 2015 HCPCS G9060 Oncology; practice guidelines; management differs from guidelines for reason(s) associated with patient comorbid illness or performance status not factored into guidelines (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9061 Oncology; practice guidelines; patient's condition not addressed by available guidelines (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9062 Oncology; practice guidelines; management differs from guidelines for other reason(s) not listed (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9063 Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage i (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved
  • 2015 HCPCS G9064 Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage ii (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved
  • 2015 HCPCS G9065 Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage iii a (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-appro
  • 2015 HCPCS G9066 Oncology; disease status; limited to non-small cell lung cancer; stage iii b- iv at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9067 Oncology; disease status; limited to non-small cell lung cancer; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9068 Oncology; disease status; limited to small cell and combined small cell/non-small cell; extent of disease initially established as limited with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration pro
  • 2015 HCPCS G9069 Oncology; disease status; small cell lung cancer, limited to small cell and combined small cell/non-small cell; extensive stage at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9070 Oncology; disease status; small cell lung cancer, limited to small cell and combined small cell/non-small; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9071 Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage i or stage iia-iib; or t3, n1, m0; and er and/or pr positive; with no evidence of disease progression, recu
  • 2015 HCPCS G9072 Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage i, or stage iia-iib; or t3, n1, m0; and er and pr negative; with no evidence of disease progression, recurr
  • 2015 HCPCS G9073 Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage iiia-iiib; and not t3, n1, m0; and er and/or pr positive; with no evidence of disease progression, recurren
  • 2015 HCPCS G9074 Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage iiia-iiib; and not t3, n1, m0; and er and pr negative; with no evidence of disease progression, recurrence,
  • 2015 HCPCS G9075 Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration proj
  • 2015 HCPCS G9077 Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t1-t2c and gleason 2-7 and psa < or equal to 20 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved
  • 2015 HCPCS G9078 Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t2 or t3a gleason 8-10 or psa > 20 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration
  • 2015 HCPCS G9079 Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t3b-t4, any n; any t, n1 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9080 Oncology; disease status; prostate cancer, limited to adenocarcinoma; after initial treatment with rising psa or failure of psa decline (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9083 Oncology; disease status; prostate cancer, limited to adenocarcinoma; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9084 Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-3, n0, m0 with no evidence of disease progression, recurrence, or metastases (for use in a medicare-
  • 2015 HCPCS G9085 Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t4, n0, m0 with no evidence of disease progression, recurrence, or metastases (for use in a medicare-ap
  • 2015 HCPCS G9086 Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-4, n1-2, m0 with no evidence of disease progression, recurrence, or metastases (for use in a medicar
  • 2015 HCPCS G9087 Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive with current clinical, radiologic, or biochemical evidence of disease (for use in a
  • 2015 HCPCS G9088 Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive without current clinical, radiologic, or biochemical evidence of disease (for use i
  • 2015 HCPCS G9089 Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9090 Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-2, n0, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurren
  • 2015 HCPCS G9091 Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t3, n0, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence
  • 2015 HCPCS G9092 Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-3, n1-2, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurr
  • 2015 HCPCS G9093 Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t4, any n, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurre
  • 2015 HCPCS G9094 Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9095 Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9096 Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease initially established as t1-t3, n0-n1 or nx (prior to neo-adjuvant therapy, if any) with no evidence of disease p
  • 2015 HCPCS G9097 Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease initially established as t4, any n, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progr
  • 2015 HCPCS G9098 Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9099 Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9100 Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; post r0 resection (with or without neoadjuvant therapy) with no evidence of disease recurrence, progression, or metastases (for use in a medicare-approved demons
  • 2015 HCPCS G9101 Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; post r1 or r2 resection (with or without neoadjuvant therapy) with no evidence of disease progression, or metastases (for use in a medicare-approved demonstratio
  • 2015 HCPCS G9102 Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; clinical or pathologic m0, unresectable with no evidence of disease progression, or metastases (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9103 Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; clinical or pathologic m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9104 Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9105 Oncology; disease status; pancreatic cancer, limited to adenocarcinoma as predominant cell type; post r0 resection without evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9106 Oncology; disease status; pancreatic cancer, limited to adenocarcinoma; post r1 or r2 resection with no evidence of disease progression, or metastases (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9107 Oncology; disease status; pancreatic cancer, limited to adenocarcinoma; unresectable at diagnosis, m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9108 Oncology; disease status; pancreatic cancer, limited to adenocarcinoma; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9109 Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; extent of disease initially established as t1-t2 and n0, m0 (prior to neo-adjuvant therapy, if any) with no
  • 2015 HCPCS G9110 Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; extent of disease initially established as t3-4 and/or n1-3, m0 (prior to neo-adjuvant therapy, if any) with
  • 2015 HCPCS G9111 Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration
  • 2015 HCPCS G9112 Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration
  • 2015 HCPCS G9113 Oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage ia-b (grade 1) without evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9114 Oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage ia-b (grade 2-3); or stage ic (all grades); or stage ii; without evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstrat
  • 2015 HCPCS G9115 Oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage iii-iv; without evidence of progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9116 Oncology; disease status; ovarian cancer, limited to epithelial cancer; evidence of disease progression, or recurrence, and/or platinum resistance (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9117 Oncology; disease status; ovarian cancer, limited to epithelial cancer; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9123 Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; chronic phase not in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9124 Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; accelerated phase not in hematologic cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9125 Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; blast phase not in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9126 Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9128 Oncology; disease status; limited to multiple myeloma, systemic disease; smoldering, stage i (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9129 Oncology; disease status; limited to multiple myeloma, systemic disease; stage ii or higher (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9130 Oncology; disease status; limited to multiple myeloma, systemic disease; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9131 Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration proje
  • 2015 HCPCS G9132 Oncology; disease status; prostate cancer, limited to adenocarcinoma; hormone-refractory/androgen-independent (e.g., rising psa on anti-androgen therapy or post-orchiectomy); clinical metastases (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9133 Oncology; disease status; prostate cancer, limited to adenocarcinoma; hormone-responsive; clinical metastases or m1 at diagnosis (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9134 Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; stage i, ii at diagnosis, not relapsed, not refractory (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9135 Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; stage iii, iv, not relapsed, not refractory (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9136 Oncology; disease status; non-hodgkin's lymphoma, transformed from original cellular diagnosis to a second cellular classification (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9137 Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; relapsed/refractory (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9138 Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; diagnostic evaluation, stage not determined, evaluation of possible relapse or non-response to therapy, or not listed (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9139 Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; extent of disease unknown, staging in progress, not listed (for use in a medicare-approved demonstration project)
  • 2015 HCPCS G9140 Frontier extended stay clinic demonstration; for a patient stay in a clinic approved for the cms demonstration project; the following measures should be present: the stay must be equal to or greater than 4 hours; weather or other conditions must prevent t
  • 2015 HCPCS G9141 TERMINATED 12/31/2012 : Influenza a (h1n1) immunization administration (includes the physician counseling the patient/family)
  • 2015 HCPCS G9142 TERMINATED 12/31/2012 : Influenza a (h1n1) vaccine, any route of administration
  • 2015 HCPCS G9143 Warfarin responsiveness testing by genetic technique using any method, any number of specimen(s)
  • 2015 HCPCS G9147 Outpatient intravenous insulin treatment (oivit) either pulsatile or continuous, by any means, guided by the results of measurements for: respiratory quotient; and/or, urine urea nitrogen (uun); and/or, arterial, venous or capillary glucose; and/or potass
  • 2015 HCPCS G9148 National committee for quality assurance - level 1 medical home
  • 2015 HCPCS G9149 National committee for quality assurance - level 2 medical home
  • 2015 HCPCS G9150 National committee for quality assurance - level 3 medical home
  • 2015 HCPCS G9151 Mapcp demonstration - state provided services
  • 2015 HCPCS G9152 Mapcp demonstration - community health teams
  • 2015 HCPCS G9153 Mapcp demonstration - physician incentive pool
  • 2015 HCPCS G9156 Evaluation for wheelchair requiring face to face visit with physician
  • 2015 HCPCS G9157 Transesophageal doppler measurement of cardiac output (including probe placement, image acquisition, and interpretation per course of treatment) for monitoring purposes
  • 2015 HCPCS G9158 Motor speech functional limitation, discharge status, at discharge from therapy or to end reporting
  • 2015 HCPCS G9159 Spoken language comprehension functional limitation, current status at therapy episode outset and at reporting intervals
  • 2015 HCPCS G9160 Spoken language comprehension functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting
  • 2015 HCPCS G9161 Spoken language comprehension functional limitation, discharge status, at discharge from therapy or to end reporting
  • 2015 HCPCS G9162 Spoken language expression functional limitation, current status at therapy episode outset and at reporting intervals
  • 2015 HCPCS G9163 Spoken language expression functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting
  • 2015 HCPCS G9164 Spoken language expression functional limitation, discharge status at discharge from therapy or to end reporting
  • 2015 HCPCS G9165 Attention functional limitation, current status at therapy episode outset and at reporting intervals
  • 2015 HCPCS G9166 Attention functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting
  • 2015 HCPCS G9167 Attention functional limitation, discharge status at discharge from therapy or to end reporting
  • 2015 HCPCS G9168 Memory functional limitation, current status at therapy episode outset and at reporting intervals
  • 2015 HCPCS G9169 Memory functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting
  • 2015 HCPCS G9170 Memory functional limitation, discharge status at discharge from therapy or to end reporting
  • 2015 HCPCS G9171 Voice functional limitation, current status at therapy episode outset and at reporting intervals
  • 2015 HCPCS G9172 Voice functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting
  • 2015 HCPCS G9173 Voice functional limitation, discharge status at discharge from therapy or to end reporting
  • 2015 HCPCS G9174 Other speech language pathology functional limitation, current status at therapy episode outset and at reporting intervals
  • 2015 HCPCS G9175 Other speech language pathology functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting
  • 2015 HCPCS G9176 Other speech language pathology functional limitation, discharge status at discharge from therapy or to end reporting
  • 2015 HCPCS G9186 Motor speech functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting
  • 2015 HCPCS G9187 Bundled payments for care improvement initiative home visit for patient assessment performed by a qualified health care professional for individuals not considered homebound including, but not limited to, assessment of safety, falls, clinical status, flui
  • 2015 HCPCS G9188 Beta-blocker therapy not prescribed, reason not given
  • 2015 HCPCS G9189 Beta-blocker therapy prescribed or currently being taken
  • 2015 HCPCS G9190 Documentation of medical reason(s) for not prescribing beta-blocker therapy (eg, allergy, intolerance, other medical reasons)
  • 2015 HCPCS G9191 Documentation of patient reason(s) for not prescribing beta-blocker therapy (eg, patient declined, other patient reasons)
  • 2015 HCPCS G9192 Documentation of system reason(s) for not prescribing beta-blocker therapy (eg, other reasons attributable to the health care system)
  • 2015 HCPCS G9193 TERMINATED 12/31/2014 : Clinician documented that patient with a diagnosis of major depression was not an eligible candidate for antidepressant medication treatment or patient did not have a diagnosis of major depression
  • 2015 HCPCS G9194 TERMINATED 12/31/2014 : Patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 180 day (6 month) continuation treatment phase
  • 2015 HCPCS G9195 TERMINATED 12/31/2014 : Patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 180 day (6 months) continuation treatment phase
  • 2015 HCPCS G9196 Documentation of medical reason(s) for not ordering first or second generation cephalosporin for antimicrobial prophylaxis
  • 2015 HCPCS G9197 Documentation of order for first or second generation cephalosporin for antimicrobial prophylaxis
  • 2015 HCPCS G9198 Order for first or second generation cephalosporin for antimicrobial prophylaxis was not documented, reason not given
  • 2015 HCPCS G9199 TERMINATED 12/31/2014 : Venous thromboembolism (vte) prophylaxis not administered the day of or the day after hospital admission for documented reasons (eg, patient is ambulatory, patient expired during inpatient stay, patient already on warfarin or another anticoagulant, other
  • 2015 HCPCS G9200 TERMINATED 12/31/2014 : Venous thromboembolism (vte) prophylaxis was not administered the day of or the day after hospital admission, reason not given
  • 2015 HCPCS G9201 TERMINATED 12/31/2014 : Venous thromboembolism (vte) prophylaxis administered the day of or the day after hospital admission
  • 2015 HCPCS G9202 TERMINATED 12/31/2014 : Patients with a positive hepatitis c antibody test
  • 2015 HCPCS G9203 Rna testing for hepatitis c documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c
  • 2015 HCPCS G9204 Rna testing for hepatitis c was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given
  • 2015 HCPCS G9205 Patient starting antiviral treatmentfor hepatitis c during the measurement period
  • 2015 HCPCS G9206 Patient starting antiviral treatment for hepatitis c during the measurement period
  • 2015 HCPCS G9207 Hepatitis c genotype testing documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c
  • 2015 HCPCS G9208 Hepatitis c genotype testing was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given
  • 2015 HCPCS G9209 Hepatitis c quantitative rna testing documented as performed between 4-12 weeks after the initiation of antiviral treatment
  • 2015 HCPCS G9210 Hepatitis c quantitative rna testing not performed between 4-12 weeks after the initiation of antiviral treatment for documented reason(s) (e.g., patients whose treatment was discontinued during the testing period prior to testing, other medical reasons,
  • 2015 HCPCS G9211 Hepatitis c quantitative rna testing was not documented as performed between 4-12 weeks after the initiation of antiviral treatment, reason not given
  • 2015 HCPCS G9212 Dsm-ivtm criteria for major depressive disorder documented at the initial evaluation
  • 2015 HCPCS G9213 Dsm-iv-tr criteria for major depressive disorder not documented at the initial evaluation, reason not otherwise specified
  • 2015 HCPCS G9214 TERMINATED 12/31/2014 : Cd4+ cell count or cd4+ cell percentage results documented
  • 2015 HCPCS G9215 TERMINATED 12/31/2014 : Cd4+ cell count or percentage not documented as performed, reason not given
  • 2015 HCPCS G9216 TERMINATED 12/31/2014 : Pcp prophylaxis was not prescribed at time of diagnosis of hiv, reason not given
  • 2015 HCPCS G9217 Pcp prophylaxis was not prescribed within 3 months of low cd4+ cell count below 200 cells/mm3, reason not given
  • 2015 HCPCS G9218 TERMINATED 12/31/2014 : Pcp prophylaxis was not prescribed within 3 months oflow cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%, reason not given
  • 2015 HCPCS G9219 Pneumocystis jiroveci pneumonia prophylaxis not prescribed within 3 months of low cd4+ cell count below 200 cells/mm3 for medical reason (i.e., patient's cd4+ cell count above threshold within 3 months after cd4+ cell count below threshold, indicating tha
  • 2015 HCPCS G9220 TERMINATED 12/31/2014 : Pneumocystis jiroveci pneumonia prophylaxis not prescribed within 3 months of low cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15% for medical reason (i.e., patient's cd4+ cell count above threshold within 3 months after cd4+ cell count b
  • 2015 HCPCS G9221 TERMINATED 12/31/2014 : Pneumocystis jiroveci pneumonia prophlaxis prescribed
  • 2015 HCPCS G9222 Pneumocystis jiroveci pneumonia prophylaxis prescribed wthin 3 months of low cd4+ cell count below 200 cells/mm3
  • 2015 HCPCS G9223 Pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%
  • 2015 HCPCS G9224 TERMINATED 12/31/2014 : Documentation of medical reason for not performing foot exam (e.g., patient with bilateral foot/leg amputation)
  • 2015 HCPCS G9225 Foot exam was not performed, reason not given
  • 2015 HCPCS G9226 Foot examination performed (includes examination through visual inspection, sensory exam with monofilament, and pulse exam - report when all of the 3 components are completed)
  • 2015 HCPCS G9227 Functional outcome assessment documented, care plan not documented, documentation the patient is not eligible for a care plan
  • 2015 HCPCS G9228 Chlamydia, gonorrhea and syphilis screening results documented (report when results are present for all of the 3 screenings)
  • 2015 HCPCS G9229 Chlamydia, gonorrhea, and syphilis not screened, due to documented reason (patient refusal is the only allowed exclusion)
  • 2015 HCPCS G9230 Chlamydia, gonorrhea, and syphilis not screened, reason not given
  • 2015 HCPCS G9231 Documentation of end stage renal disease (esrd), dialysis, renal transplant or pregnancy
  • 2015 HCPCS G9232 Clinician treating major depressive disorder did not communicate to clinician treating comorbid condition for specified patient reason
  • 2015 HCPCS G9233 All quality actions for the applicable measures in the total knee replacement measures group have been performed for this patient
  • 2015 HCPCS G9234 I intend to report the total knee replacement measures group
  • 2015 HCPCS G9235 All quality actions for the applicable measures in the general surgery measures group have been performed for this patient
  • 2015 HCPCS G9236 All quality actions for the applicable measures in the optimizing patient exposure to ionizing radiation measures group have been performed for this patient
  • 2015 HCPCS G9237 I intend to report the general surgery measures group
  • 2015 HCPCS G9238 I intend to report the optimizing patient exposure to ionizing radiation measures group
  • 2015 HCPCS G9239 Documentation of reasons for patient initiaiting maintenance hemodialysis with a catheter as the mode of vascular access (eg, patient has a maturing avf/avg, time-limited trial of hemodialysis, patients undergoing palliative dialysis, other medical reason
  • 2015 HCPCS G9240 Patient whose mode of vascular access is a catheter at the time maintenance hemodialysis is initiated
  • 2015 HCPCS G9241 Patient whose mode of vascular access is not a catheter at the time maintenance hemodialysis is initiated
  • 2015 HCPCS G9242 Documentation of viral load equal to or greater than 200 copies/ml or viral load not performed
  • 2015 HCPCS G9243 Documentation of viral load less than 200 copies/ml
  • 2015 HCPCS G9244 Antiretroviral thereapy not prescribed
  • 2015 HCPCS G9245 Antiretroviral therapy prescribed
  • 2015 HCPCS G9246 Patient did not have at least one medical visit in each 6 month period of the 24 month measurement period, with a minimum of 60 days between medical visits
  • 2015 HCPCS G9247 Patient had at least one medical visit in each 6 month period of the 24 month measurement period, with a minimum of 60 days between medical visits
  • 2015 HCPCS G9248 TERMINATED 12/31/2014 : Patient did not have a medical visit in the last 6 months
  • 2015 HCPCS G9249 TERMINATED 12/31/2014 : Patient had a medical visit in the last 6 months
  • 2015 HCPCS G9250 Documentation of patient pain brought to a comfortable level within 48 hours from initial assessment
  • 2015 HCPCS G9251 Documentation of patient with pain not brought to a comfortable level within 48 hours from initial assessment
  • 2015 HCPCS G9252 TERMINATED 12/31/2014 : Adenoma(s) or other neoplasm detected during screening colonoscopy
  • 2015 HCPCS G9253 TERMINATED 12/31/2014 : Adenoma(s) or other neoplasm not detected during screening colonoscopy
  • 2015 HCPCS G9254 Documentation of patient discharged to home later than post-operative day 2 following cas
  • 2015 HCPCS G9255 Documentation of patient discharged to home no later than post operative day 2 following cas
  • 2015 HCPCS G9256 Documentation of patient death following cas
  • 2015 HCPCS G9257 Documentation of patient stroke following cas
  • 2015 HCPCS G9258 Documentation of patient stroke following cea
  • 2015 HCPCS G9259 Documentation of patient survival and absence of stroke following cas
  • 2015 HCPCS G9260 Documentation of patient death following cea
  • 2015 HCPCS G9261 Documentation of patient survival and absence of stroke following cea
  • 2015 HCPCS G9262 Documentation of patient death in the hospital following endovascular aaa repair
  • 2015 HCPCS G9263 Documentation of patient survival in the hospital following endovascular aaa repair
  • 2015 HCPCS G9264 Documentation of patient receiving maintenance hemodialysis for greater than or equal to 90 days with a catheter for documented reasons (eg, patient is undergoing palliative dialysis with a catheter, patient approved by a qualified transplant program and
  • 2015 HCPCS G9265 Patient receiving maintenance hemodialysis for greater than or equal to 90 days with a catheter as the mode of vascular access
  • 2015 HCPCS G9266 Patient receiving maintenance hemodialysis for greater than or equal to 90 days without a catheter as the mode of vascular access
  • 2015 HCPCS G9267 Documentation of patient with one or more complications or mortality within 30 days
  • 2015 HCPCS G9268 Documentation of patient with one or more complications within 90 days
  • 2015 HCPCS G9269 Documentation of patient without one or more complications and without mortality within 30 days
  • 2015 HCPCS G9270 Documentation of patient without one or more complications within 90 days
  • 2015 HCPCS G9271 TERMINATED 12/31/2014 : Ldl value < 100
  • 2015 HCPCS G9272 TERMINATED 12/31/2014 : Ldl value >= 100
  • 2015 HCPCS G9273 Blood pressure has a systolic value of < 140 and a diastolic value of < 90
  • 2015 HCPCS G9274 Blood pressure has a systolic value of =140 and a diastolic value of = 90 or systolic value < 140 and diastolic value = 90 or systolic value = 140 and diastolic value < 90
  • 2015 HCPCS G9275 Documentation that patient is a current non-tobacco user
  • 2015 HCPCS G9276 Documentation that patient is a current tobacco user
  • 2015 HCPCS G9277 Documentation that the patient is on daily aspirin or anti-platelet or has documentation of a valid contraindication to aspirin/anti-platelet. automatic contraindications include anti-coagulant use, allergy, and history of gastrointestinal bleed. additi
  • 2015 HCPCS G9278 Documentation that the patient is not on daily aspirin or anti-platelet regimen
  • 2015 HCPCS G9279 Pneumococcal screening performed and documentation of vaccination received prior to discharge
  • 2015 HCPCS G9280 Pneumococcal vaccination not administered prior to discharge, reason not specified
  • 2015 HCPCS G9281 Screening performed and documentation that vaccination not indicated/patient refusal
  • 2015 HCPCS G9282 Documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g., biopsy taken for other purposes in a patient with a history of non-small cell lung cancer or other documented medical reasons
  • 2015 HCPCS G9283 Non small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation
  • 2015 HCPCS G9284 Non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation
  • 2015 HCPCS G9285 Specimen site other than anatomic location of lung or is not classified as non small cell lung cancer
  • 2015 HCPCS G9286 Documentation of antibiotic regimen prescribed within 7 days of diagnosis or within 10 days after onset of symptoms
  • 2015 HCPCS G9287 No antibiotic regimen prescribed within 7 days of diagnosis or within 10 days after onset of symptoms
  • 2015 HCPCS G9288 Documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g., a solitary fibrous tumor in a person with a history of non-small cell carcinoma or other documented medical reasons )
  • 2015 HCPCS G9289 Non small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation
  • 2015 HCPCS G9290 Non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation
  • 2015 HCPCS G9291 Specimen site other than anatomic location of lung, is not classified as non small cell lung cancer or classified as nsclc-nos
  • 2015 HCPCS G9292 Documentation of medical reason(s) for not reporting pt category and a statement on thickness and ulceration and for pt1, mitotic rate (e.g., negative skin biopsies in a patient with a history of melanoma or other documented medical reasons)
  • 2015 HCPCS G9293 Pathology report does not include the pt category and a statement on thickness and ulceration and for pt1, mitotic rate
  • 2015 HCPCS G9294 Pathology report includes the pt category and a statement on thickness and ulceration and for pt1, mitotic rate
  • 2015 HCPCS G9295 Specimen site other than anatomic cutaneous location
  • 2015 HCPCS G9296 Patients with documented shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure
  • 2015 HCPCS G9297 Shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure, not documented, reason not given
  • 2015 HCPCS G9298 Patients who are evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g., history of dvt, pe, mi, arrhythmia and stroke)
  • 2015 HCPCS G9299 Patients who are not evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure including (e.g., history of dvt, pe, mi, arrhythmia and stroke, reason not given)
  • 2015 HCPCS G9300 Documentation of medical reason(s) for not completely infusing the prophylactic antibiotic prior to the inflation of the proximal tourniquet (e.g., a tourniquet was not used)
  • 2015 HCPCS G9301 Patients who had the prophylactic antibiotic completely infused prior to the inflation of the proximal tourniquet
  • 2015 HCPCS G9302 Prophylactic antibiotic not completely infused prior to the inflation of the proximal tourniquet, reason not given
  • 2015 HCPCS G9303 Operative report does not identify the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant, reason not given
  • 2015 HCPCS G9304 Operative report identifies the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant
  • 2015 HCPCS G9305 Intervention for presence of leak of endoluminal contents through an anastomosis not required
  • 2015 HCPCS G9306 Intervention for presence of leak of endoluminal contents through an anastomosis required
  • 2015 HCPCS G9307 No return to the operating room for a surgical procedure, for any reason, within 30 days of the principal operative procedure
  • 2015 HCPCS G9308 Unplanned return to the operating room for a surgical procedure, for any reason, within 30 days of the principal operative procedure
  • 2015 HCPCS G9309 No unplanned hospital readmission within 30 days of principal procedure
  • 2015 HCPCS G9310 Unplanned hospital readmission within 30 days of principal procedure
  • 2015 HCPCS G9311 No surgical site infection
  • 2015 HCPCS G9312 Surgical site infection
  • 2015 HCPCS G9313 Amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis for documented reason (eg, cystic fibrosis, immotile cilia disorders, ciliary dyskinesia, immune deficiency, prior history of sinus surgery within t
  • 2015 HCPCS G9314 Amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis, reason not given
  • 2015 HCPCS G9315 Documentation amoxicillin, with or without clavulanate, prescribed as a first line antibiotic at the time of diagnosis
  • 2015 HCPCS G9316 Documentation of patient-specific risk assessment with a risk calculator based on multi-institutional clinical data, the specific risk calculator used, and communication of risk assessment from risk calculator with the patient or family
  • 2015 HCPCS G9317 Documentation of patient-specific risk assessment with a risk calculator based on multi-institutional clinical data, the specific risk calculator used, and communication of risk assessment from risk calculator with the patient or family not completed
  • 2015 HCPCS G9318 Imaging study named according to standardized nomenclature
  • 2015 HCPCS G9319 Imaging study not named according to standardized nomenclature, reason not given
  • 2015 HCPCS G9320 Documentation of medical reason(s) for not naming ct studies according to a standardized nomenclature provided (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)
  • 2015 HCPCS G9321 Count of previous ct (any type of ct) and cardiac nuclear medicine (myocardial perfusion) studies documented in the 12-month period prior to the current study
  • 2015 HCPCS G9322 Count of previous ct and cardiac nuclear medicine (myocardial perfusion) studies not documented in the 12-month period prior to the current study, reason not given
  • 2015 HCPCS G9323 Documentation of medical reason(s) for not counting previous ct and cardiac nuclear medicine (myocardial perfusion) studies (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)
  • 2015 HCPCS G9324 All necessary data elements not included, reason not given
  • 2015 HCPCS G9325 Ct studies not reported to a radiation dose index registry due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)
  • 2015 HCPCS G9326 Ct studies performed not reported to a radiation dose index registry, reason not given
  • 2015 HCPCS G9327 Ct studies performed reported to a radiation dose index registry with all necessary data elements
  • 2015 HCPCS G9328 Dicom format image data availability not documented in final report due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)
  • 2015 HCPCS G9329 Dicom format image data available to non-affiliated external healthcare facilities or entities on a secure, media free, reciprocally searchable basis with patient authorization for at least a 12-month period after the study not documented in final report,
  • 2015 HCPCS G9340 Final report documented that dicom format image data available to non-affiliated external healthcare facilities or entities on a secure, media free, reciprocally searchable basis with patient authorization for at least a 12-month period after the study
  • 2015 HCPCS G9341 Search conducted for prior patient ct studies completed at non-affiliated external healthcare facilities or entities within the past 12-months and are available through a secure, authorized, media-free, shared archive prior to an imaging study being perfo
  • 2015 HCPCS G9342 Search not conducted prior to an imaging study being performed for prior patient ct studies completed at non-affiliated external healthcare facilities or entities within the past 12-months and are available through a secure, authorized, media-free, shared
  • 2015 HCPCS G9343 Due to medical reasons, search not conducted for dicom format images for prior patient ct imaging studies completed at non-affiliated external heatlhcare facilities or entities within the past 12 months that are available through a secure, authorized, med
  • 2015 HCPCS G9344 Due to system reasons search not conducted for dicom format images for prior patient ct imaging studies completed at non-affiliated external healthcare facilities or entities within the past 12 months that are available through a secure, authorized, media
  • 2015 HCPCS G9345 Follow-up recommendations documented according to recommended guidelines for incidentally detected pulmonary nodules (e.g., follow-up ct imaging studies needed or that no follow-up is needed) based at a minimum on nodule size and patient risk factors
  • 2015 HCPCS G9346 Follow-up recommendations not documented according to recommended guidelines for incidentally detected pulmonary nodules due to medical reasons (e.g., patients with known malignant disease, patients with unexplained fever, ct studies performed for radiati
  • 2015 HCPCS G9347 Follow-up recommendations not documented according to recommended guidelines for incidentally detected pulmonary nodules, reason not given
  • 2015 HCPCS G9348 Ct scan of the paranasal sinuses ordered at the time of diagnosis for documented reasons (eg, persons with sinusitis symptoms lasting at least 7 to 10 days, antibiotic resistance, immunocompromised, recurrent sinusitis, acute frontal sinusitis, acute sphe
  • 2015 HCPCS G9349 Documentation of a ct scan of the paranasal sinuses ordered at the time of diagnosis or received within 28 days after date of diagnosis
  • 2015 HCPCS G9350 Ct scan of the paranasal sinuses not ordered at the time of diagnosis or received within 28 days after date of diagnosis
  • 2015 HCPCS G9351 More than one ct scan of the paranasal sinuses ordered or received within 90 days after diagnosis
  • 2015 HCPCS G9352 More than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis, reason not given
  • 2015 HCPCS G9353 More than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis for documented reasons (eg, patients with complications, second ct obtained prior to surgery, other medical reasons)
  • 2015 HCPCS G9354 More than one ct scan of the paranasal sinuses not ordered within 90 days after the date of diagnosis
  • 2015 HCPCS G9355 Elective delivery or early induction not performed
  • 2015 HCPCS G9356 Elective delivery or early induction performed
  • 2015 HCPCS G9357 Post-partum screenings, evaluations and education performed
  • 2015 HCPCS G9358 Post-partum screenings, evaluations and education not performed
  • 2015 HCPCS G9359 Documentation of negative or managed positive tb screen with further evidence that tb is not active
  • 2015 HCPCS G9360 No documentation of negative or managed positive tb screen
  • 2015 HCPCS G9361 Medical indication for induction (documentation of reason(s) for elective delivery or early induction (e.g., hemorrhage and placental complications, hypertension, preeclampsia and eclampsia, rupture of membranes-premature, prolonged maternal conditions co
  • 2015 HCPCS G9362 Duration of monitored anesthesia care (mac) or peripheral nerve block (pnb) without the use of general anesthesia during an applicable procedure 60 minutes or longer, as documented in the anesthesia record
  • 2015 HCPCS G9363 Duration of monitored anesthesia care (mac) or peripheral nerve block (pnb) without the use of general anesthesia during an applicable procedure or general or neuraxial anesthesia less than 60 minutes, as documented in the anesthesia record
  • 2015 HCPCS G9364 Sinusitis caused by, or presumed to be caused by, bacterial infection
  • 2015 HCPCS G9365 One high-risk medication ordered
  • 2015 HCPCS G9366 One high-risk medication not ordered
  • 2015 HCPCS G9367 At least two different high-risk medications ordered
  • 2015 HCPCS G9368 At least two different high-risk medications not ordered
  • 2015 HCPCS G9369 Individual filled at least two prescriptions for any antipsychotic medication and had a pdc of 0.8 or greater
  • 2015 HCPCS G9370 Individual who did not fill at least two prescriptions for any antipsychotic medication or did not have a pdc of 0.8 or greater
  • 2015 HCPCS G9376 Patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month) following only one surgery
  • 2015 HCPCS G9377 Patient did not have the retina attached after 6 months following only one surgery
  • 2015 HCPCS G9378 Patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month)
  • 2015 HCPCS G9379 Patient did not achieve flat retinas six months post surgery
  • 2015 HCPCS G9380 Patient offered assistance with end of life issues during the measurement period
  • 2015 HCPCS G9381 Documentation of medical reason(s) for not offering assistance with end of life issues (eg, patient in hospice and in terminal phase) during the measurement period
  • 2015 HCPCS G9382 Patient not offered assistance with end of life issues during the measurement period
  • 2015 HCPCS G9383 Patient received screening for hcv infection within the 12 month reporting period
  • 2015 HCPCS G9384 Documentation of medical reason(s) for not receiving screening for hcv infection within the 12 month reporting period (e.g., decompensated cirrhosis including advanced disease [ie, ascites, esophageal variceal bleeding, hepatic encephalopathy], hepatocell
  • 2015 HCPCS G9385 Documentation of patient reason(s) for not receiving screening for hcv infection within the 12 month reporting period (e.g., patient declined, other patient reasons)
  • 2015 HCPCS G9386 Screening for hcv infection not received within the 12 month reporting period, reason not given
  • 2015 HCPCS G9389 Unplanned rupture of the posterior capsule requiring vitrectomy
  • 2015 HCPCS G9390 No unplanned rupture of the posterior capsule requiring vitrectomy
  • 2015 HCPCS G9391 Patient achieves refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visit
  • 2015 HCPCS G9392 Patient does not achieve refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visit
  • 2015 HCPCS G9393 Patient with an initial phq-9 score greater than nine who achieves remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score of less than five
  • 2015 HCPCS G9394 Patient who had a diagnosis of bipolar disorder or personality disorder, death, permanent nursing home resident or receiving hospice or palliative care any time during the measurement or assessment period
  • 2015 HCPCS G9395 Patient with an initial phq-9 score greater than nine who did not achieve remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score greater than or equal to five
  • 2015 HCPCS G9396 Patient with an initial phq-9 score greater than nine who was not assessed for remission at twelve months (+/- 30 days)
  • 2015 HCPCS G9399 Documentation in the patient record of a discussion between the physician/clinician and the patient that includes all of the following: treatment choices appropriate to genotype, risks and benefits, evidence of effectiveness, and patient preferences towar
  • 2015 HCPCS G9400 Documentation of medical or patient reason(s) for not discussing treatment options; medical reasons: patient is not a candidate for treatment due to advanced physical or mental health comorbidity (including active substance use); currently receiving anti
  • 2015 HCPCS G9401 No documentation of a discussion in the patient record of a discussion between the physician or other qualfied healthcare professional and the patient that includes all of the following: treatment choices appropriate to genotype, risks and benefits, evide
  • 2015 HCPCS G9402 Patient received follow-up on the date of discharge or within 30 days after discharge
  • 2015 HCPCS G9403 Clinician documented reason patient was not able to complete 30 day follow-up from acute inpatient setting discharge (e.g., patient death prior to follow-up visit, patient non-compliant for visit follow-up)
  • 2015 HCPCS G9404 Patient did not receive follow-up on the date of discharge or within 30 days after discharge
  • 2015 HCPCS G9405 Patient received follow-up within 7 days from discharge
  • 2015 HCPCS G9406 Clinician documented reason patient was not able to complete 7 day follow-up from acute inpatient setting discharge (i.e patient death prior to follow-up visit, patient non-compliance for visit follow-up)
  • 2015 HCPCS G9407 Patient did not receive follow-up on or within 7 days after discharge
  • 2015 HCPCS G9408 Patients with cardiac tamponade and/or pericardiocentesis occurring within 30 days
  • 2015 HCPCS G9409 Patients without cardiac tamponade and/or pericardiocentesis occurring within 30 days
  • 2015 HCPCS G9410 Patient admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision
  • 2015 HCPCS G9411 Patient not admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision
  • 2015 HCPCS G9412 Patient admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision
  • 2015 HCPCS G9413 Patient not admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision
  • 2015 HCPCS G9414 Patient had one dose of meningococcal vaccine on or between the patient's 11th and 13th birthdays
  • 2015 HCPCS G9415 Patient did not have one dose of meningococcal vaccine on or between the patient's 11th and 13th birthdays
  • 2015 HCPCS G9416 Patient had one tetanus, diphtheria toxoids and acellular pertussis vaccine (tdap) or one tetanus, diphtheria toxoids vaccine (td) on or between the patient's 10th and 13th birthdays or one tetanus and one diptheria vaccine on or between the patient's 10t
  • 2015 HCPCS G9417 Patient did not have one tetanus, diphtheria toxoids and acellular pertussis vaccine (tdap) or one tetanus, diphtheria toxoids vaccine (td) on or between the patient's 10th and 13th birthdays or one tetanus and one diptheria vaccine on or between the pati
  • 2015 HCPCS G9418 Primary non-small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation
  • 2015 HCPCS G9419 Documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g., biopsy taken for other purposes in a patient with a history of primary non-small cell lung cancer or other documented medical
  • 2015 HCPCS G9420 Specimen site other than anatomic location of lung or is not classified as primary non-small cell lung cancer
  • 2015 HCPCS G9421 Primary non-small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation
  • 2015 HCPCS G9422 Non-small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation
  • 2015 HCPCS G9423 Documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g., a solitary fibrous tumor in a person with a history of non-small cell carcinoma or other documented medical reasons)
  • 2015 HCPCS G9424 Specimen site other than anatomic location of lung, is not classified as non-small cell lung cancer or classified as nsclc-nos
  • 2015 HCPCS G9425 Non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation
  • 2015 HCPCS G9426 Improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration performed for ed admitted patients
  • 2015 HCPCS G9427 Improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration not performed for ed admitted patients
  • 2015 HCPCS G9428 Pathology report includes the pt category and a statement on thickness and ulceration and for pt1, mitotic rate
  • 2015 HCPCS G9429 Documentation of medical reason(s) for not reporting pt category and a statement on thickness and ulceration and for pt1, mitotic rate (e.g., negative skin biopsies in a patient with a history of melanoma or other documented medical reasons)
  • 2015 HCPCS G9430 Specimen site other than anatomic cutaneous location
  • 2015 HCPCS G9431 Pathology report does not include the pt category and a statement on thickness and ulceration and for pt1, mitotic rate
  • 2015 HCPCS G9432 Asthma well-controlled based on the act, c-act, acq, or ataq score and results documented
  • 2015 HCPCS G9433 Death, permanent nursing home resident or receiving hospice or palliative care any time during the measurement period
  • 2015 HCPCS G9434 Asthma not well-controlled based on the act, c-act, acq, or ataq score, or specified asthma control tool not used, reason not given
  • 2015 HCPCS G9435 Aspirin prescribed at discharge
  • 2015 HCPCS G9436 Aspirin not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)
  • 2015 HCPCS G9437 Aspirin not prescribed at discharge
  • 2015 HCPCS G9438 P2y inhibitor prescribed at discharge
  • 2015 HCPCS G9439 P2y inhibitor not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)
  • 2015 HCPCS G9440 P2y inhibitor not prescribed at discharge
  • 2015 HCPCS G9441 Statin prescribed at discharge
  • 2015 HCPCS G9442 Statin not prescribed for documented reasons (e.g., allergy, medical intolerance)
  • 2015 HCPCS G9443 Statin not prescribed at discharge
  • 2015 HCPCS G9448 Patients who were born in the years 1945?1965
  • 2015 HCPCS G9449 History of receiving blood transfusions prior to 1992
  • 2015 HCPCS G9450 History of injection drug use
  • 2015 HCPCS G9451 Patient received one-time screening for hcv infection
  • 2015 HCPCS G9452 Documentation of medical reason(s) for not receiving one-time screening for hcv infection (e.g., decompensated cirrhosis indicating advanced disease [ie, ascites, esophageal variceal bleeding, hepatic encephalopathy], hepatocellular carcinoma, waitlist fo
  • 2015 HCPCS G9453 Documentation of patient reason(s) for not receiving one-time screening for hcv infection (e.g., patient declined, other patient reasons)
  • 2015 HCPCS G9454 One-time screening for hcv infection not received within 12 month reporting period and no documentation of prior screening for hcv infection, reason not given
  • 2015 HCPCS G9455 Patient underwent abdominal imaging with ultrasound, contrast enhanced ct or contrast mri for hcc
  • 2015 HCPCS G9456 Documentation of medical or patient reason(s) for not ordering or performing screening for hcc. medical reason: comorbid medical conditions with expected survival < 5 years, hepatic decompensation and not a candidate for liver transplantation, or other m
  • 2015 HCPCS G9457 Patient did not undergo abdominal imaging and did not have a documented reason for not undergoing abdominal imaging in the reporting period
  • 2015 HCPCS G9458 Patient documented as tobacco user and received tobacco cessation intervention (must include at least one of the following: advice given to quit smoking or tobacco use, counseling on the benefits of quitting smoking or tobacco use, assistance with or refe
  • 2015 HCPCS G9459 Currently a tobacco non-user
  • 2015 HCPCS G9460 Tobacco assessment or tobacco cessation intervention not performed, reason not otherwise specified
  • 2015 HCPCS G9463 I intend to report the sinusitis measures group
  • 2015 HCPCS G9464 All quality actions for the applicable measures in the sinusitis measures group have been performed for this patient
  • 2015 HCPCS G9465 I intend to report the acute otitis externa (aoe) measures group
  • 2015 HCPCS G9466 All quality actions for the applicable measures in the aoe measures group have been performed for this patient
  • 2015 HCPCS G9467 Patient who have received or are receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600mg prednisone or greater for all fills
  • 2015 HCPCS G9468 Patient not receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600mg prednisone or greater for all fills
  • 2015 HCPCS G9469 Patients who have received or are receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600mg prednisone or greater for all fills
  • 2015 HCPCS G9470 Patients not receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600mg prednisone or greater for all fills
  • 2015 HCPCS G9471 Within the past 2 years, central dual-energy x-ray absorptiometry (dxa) not ordered or documented
  • 2015 HCPCS G9472 Within the past 2 years, central dual-energy x-ray absorptiometry (dxa) not ordered and documented, no review of systems and no medication history or pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribed